Proposal for a Regulation of the European Parliament and of the Council concerning the placing on the market and use of biocidal products

Inhoudsopgave van deze pagina:

Tekst
Originele weergave

Meer informatie

1. Tekst

COUNCIL OFBrussels, 13 October 2010 THE EUROPEAN UNION

6564/4/10 REV 4

Interinstitutional File:

2009/0076 (COD) ENV 82 MI 53 AGRI 56 CHIMIE 6 CODEC 126 REVISED NOTE from:

General Secretariat to: Delegations No. Cion prop.: 11063/09 ENV 440 MI 246 AGRI 267 CHIMIE 50 CODEC 849 - COM(2009) 267 final Subject: Proposal for a Regulation of the European Parliament and of the Council concerning the placing on the market and use of biocidal products

The Annex to this note contains a yet further revised draft of the above-mentioned Regulation

incorporating updated Presidency suggestions.1

The annexed text does not include the Annexes to the Regulation. Updated text reflecting the outcome of experts' discussions on the Annexes will be issued shortly.

Underlining indicates changes to the Commission's proposal and "[...]" a deletion. Grey shading indicates changes that were not in document 6564/2/10 REV 2.

___________________ 1 ANNEX

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL concerning the placing on the market and use of biocidal products (Text with EEA relevance) THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 114 thereof,

Having regard to the proposal from the Commission,

Having regard to the opinion of the European Economic and Social Committee,

After consulting the Committee of the Regions,

Acting in accordance with the ordinary legislative procedure,

Whereas:

[Recitals omitted.] HAVE ADOPTED THIS REGULATION:

CHAPTER I SCOPE AND DEFINITIONS

Article 1 Purpose and subject matter

1.

The purpose of this Regulation is to improve the functioning of the internal market through the harmonisation of the rules on the placing on the market and use of biocidal products, whilst ensuring a high level of protection of both human and animal health and the environment. The provisions of this Regulation are underpinned by the precautionary principle, the aim of which is to safeguard the health of humans, animals and the environment.
2.

This Regulation lays down rules for:

(a) the making available on the market and use of biocidal products within one or more Member States or the Union;

(b) the placing on the market of treated articles;

(d) the establishment at Union level of a list of active substances which may be used in biocidal products.

Article 2 Scope

1.

This Regulation shall apply to biocidal products and treated articles as defined in points (a)

and (k) of Article 3(1). A list of the types of biocidal products covered by this Regulation and their descriptions is set out in Annex V.

2.

Subject to any explicit provision to the contrary in this Regulation or other Union legislation, this Regulation shall not apply to biocidal products or treated articles that are within the scope of the following instruments:

(a) [...] Council Directive 90/167/EEC of 26 March 1990 laying down the conditions governing the preparation, placing on the market and use of medicated feeds in the Community ;

(b) Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices , [...] Council Directive 93/42/EEC of 14 June 1993 concerning medical devices and [...] Directive 98/79/EC of the European Parliament and of the Council of 27 October1998 on in vitro diagnostic medical devices ;

6 November 2001 on the Community code relating to veterinary medicinal products , Directive 2001/83/EC of the European Parliament and of the Council of

6 November 2001 on the Community code relating to medicinal products for human use and Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency;

(d) Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition

- ;

(e) Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of foodstuffs and Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific hygiene rules for food of animal origin ;

(f) Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives ;

(g) Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods ;

(h) Regulation (EC) No 767/2009 of the European Parliament and of the Council of 13 July 2009 on the placing on the market and use of feed;

(i) Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market ;

(j) Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.

3.

Subject to any explicit provision to the contrary in this Regulation or other Union legislation, this Regulation shall be without prejudice to the following instruments:

(a) Council Directive 67/548/EEC 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances ;

[...]

(b) Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work ;

(c) Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work (fourteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) ;

(d) Council Directive 98/83/EC of 3 November 1998 on the quality of water intended for human consumption ;

(e) Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of the laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations ;

(f) Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work ;

(g) Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a framework for Community action in the field of water policy ;

(h) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency ;

(i) Directive 2006/114/EC of 12 December 2006 of the European Parliament and of the Council concerning misleading and comparative advertising ;

(j) Regulation (EC) No 689/2008 of the European Parliament and of the Council of 17 June 2008 concerning the export and import of dangerous chemicals ;

(k) [...] Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures [...] ;

(l) Directive 2009/128/EC of the European Parliament and of the Council of 21 October 2009 establishing a framework for Community action to achieve the sustainable use of pesticides ;

(m) [...] Directive .../EC of the European Parliament and of the Council of... ... ... on the protection of animals used for scientific purposes;

(n) Directive .../EC of the European Parliament and of the Council of... ... ... on industrial emissions.

4.

Article 58 shall not apply to the carriage of biocidal products by rail, road, inland waterway, sea or air.
5.

This Regulation shall not apply to food or feed [...] used for biocidal purposes.
6.

This Regulation shall not apply to processing aids that are used for biocidal purposes.
7.

Where a biocidal product is intended by its manufacturer to be used for the purpose of exerting a controlling effect on any harmful organism present on medical devices and for other purposes covered by this Regulation, the relevant essential requirements set out in Annex I to Directive 90/385/EEC, 93/42/EEC or 98/79/EC shall also be fulfilled.
8.

Biocidal products which obtained final approval under the International Convention for the Control and Management of Ships' Ballast Water and Sediments shall be considered as authorised under Chapter VII of this Regulation. Articles 38 and 57 shall apply accordingly.
9.

Member States may allow for exemptions from this Regulation in specific cases for certain biocidal products, on their own or in a treated article, where necessary in the interests of defence.

Article 3 Definitions

1.

For the purposes of this Regulation, the following definitions shall apply:

(a) 'biocidal products' means

[...] substances, mixtures or articles in the form in which they are supplied to the user, consisting of, containing or generating one or more active substances, [...] with the primary intention of destroying, deterring, rendering harmless, preventing the action of, or otherwise exerting a controlling effect on, any harmful organism by any means other than mere physical or mechanical action [...];

(b) 'micro-organism' means

any microbiological entity, cellular or non-cellular, capable of replication or of transferring genetic material, including lower fungi, viruses, bacteria, yeasts, moulds, algae, protozoa and microscopic parasitic helminths;

a substance or a micro-organism having an action on or against harmful organisms;

(d) 'existing active substance' means

a substance which was on the market on 14 May 2000 as an active substance of a biocidal product for purposes other than scientific or product and process-orientated research and development;

(e) 'new active substance' means

a substance which was not on the market on 14 May 2000 as an active substance of a biocidal product for purposes other than scientific or product and process-orientated research and development;

(f) 'substance of concern' means

any substance, other than the active substance, which has an inherent capacity to cause an adverse effect on humans, animals or the environment and is present or is produced in a biocidal product in sufficient concentration to present risks of such an effect;

(g) 'harmful organisms means

organisms, including pathogenic agents, which have an unwanted presence or a detrimental effect on humans, their activities or the products they use or produce, or on animals or the environment;

(h) 'residues' means

substances present in or on [...] products of plant or animal origin, drinking water, food, feed or elsewhere in the environment and resulting from the use of a biocidal product, including their metabolites, breakdown or reaction products;

*

A recital could clarify that such a substance, unless there are other grounds for concern, would normally be:

a substance classified as dangerous according to Council Directive 67/548/EEC, and present in the biocidal product at a concentration leading the product to be regarded as dangerous within the meaning of Articles 5 to 7 of Directive 1999/45/EC, or

-

a substance classified as hazardous according to Regulation (EC) No 1272/2008, and present in the biocidal product at a concentration leading the product to be regarded as hazardous within the meaning of that Regulation.

(ha) 'making available on the market' means

any supply of a biocidal product or of a treated article for distribution or use on the Union market in the course of a commercial activity, whether in return for payment or free of charge;

(i) 'placing on the market' means

the first making available on the market of a biocidal product or of a treated article [...];

(j) 'use' means

all operations carried out with a biocidal product, including storage, handling, mixing and application, except any such operation carried out with a view to exporting the biocidal product or the treated [...] article outside the Union;

(k) 'treated [...] article' means

any substance, mixture [...] or article which has been treated with or incorporates one or more biocidal products;

(l) 'national authorisation' means

an administrative act by which the competent authority of a Member State authorises the placing on the market and the use of a biocidal product in its territory or in a part thereof;

(m) 'Union authorisation' means

an administrative act by which the Commission authorises the placing on the market and the use of a biocidal product in the territory of the Union or in a part thereof;

(n) 'authorisation' means

national authorisation or Union authorisation;

(na) 'product-type' means

one of the product-types specified in Annex V;

(o) 'single biocidal product' means

a biocidal product with no intended variations as to the percentage of the active [...] or

-

non-active substances [...] it contains;

(p) 'biocidal product family' means

a group of biocidal products having similar uses, containing the same active substances of the same specifications and presenting specified variations in their composition [...] which do not adversely affect the level of risk or significantly reduce the efficacy of the products;

(q) 'letter of access' means

an original document, signed by the data owner or its representative, which states that the data may be used by competent authorities, the [...] Agency, or the Commission for the purpose of evaluating an active substance or granting an authorisation for the benefit of a third party;

(r) 'food' and 'feed' mean

food as defined in Article 2 of Regulation (EC) No 178/2002 of the European Parliament and of the Council

-

and feed as defined in Article 3(4) of that Regulation;

(s) 'food contact materials' means

any material or article as referred to in Article 1(2) of Regulation (EC) No 1935/2004

- ;

(t) 'processing aid' means

any substance falling within the definition of point (b) of Article 3(2) of Regulation (EC) No 1333/2008 or point (h) of Article 2(2) of Regulation (EC) No 1831/2003;

(u) 'technical equivalence' means

similarity as regards the chemical composition and hazard profile of a substance produced from a different manufacturing source, compared to the substance of the reference source with respect to which the initial risk assessment was carried out;

(v) 'Agency' means

the European Chemicals Agency established by Regulation (EC) No 1907/2006;

(w) `advertisement' means

a means of promoting the sale or use of biocidal products by printed, electronic or other

-

media;

(x) 'nanomaterial' means

a substance or mixture that has one or more external dimensions or an internal or surface

-

structure at the nanometre range;

(y) 'professional user' means

any person who uses biocidal products in the course of their professional activities.

2.

For the purposes of this Regulation, the definitions laid down in Article 3 of Regulation (EC)

No 1907/2006 shall apply for the following terms:

(a) substance;

(b) mixture;

(d) product and process-orientated research and development;

(e) scientific research and development.

CHAPTER II INCLUSION OF AN ACTIVE SUBSTANCE IN ANNEX I

Article 4 Conditions for inclusion

1.

An active substance shall be included in Annex I for an initial period not exceeding 10 years if at least one biocidal product containing that active substance may be expected to meet the criteria laid down in point (b) of Article 16(1).
2.

Inclusion of an active substance in Annex I shall be restricted to those product-types [...] for which relevant data have been submitted in accordance with Article 6.
3.

The entry for an active substance in Annex I shall, where appropriate, specify any of the following conditions:

(a) the minimum degree of purity of the active substance;

(b) the nature and maximum content of certain impurities;

(d) manner and area of use;

(e) designation of categories of users;

(f) other particular conditions based on the evaluation of the information related to that active substance.

[...]

Article 5 Exclusion criteria

1.

The following active substances shall not, subject to paragraph 2, be included in Annex I:

(a) active substances which have been classified in accordance with Regulation (EC)

No 1272/2008 as, or which meet the criteria to be classified as, carcinogen category 1A or 1B;

(b) active substances which have been classified in accordance with Regulation (EC)

No 1272/2008 as, or which meet the criteria to be classified as, mutagen category 1A or 1B;

No 1272/2008 as, or which meet the criteria to be classified as, toxic for reproduction category 1A or 1B;

(d) active substances identified in accordance with Articles 57(f) and 59(1) of Regulation (EC) No 1907/2006 as having endocrine disrupting properties;

(e) active substances which fulfil the criteria for being persistent, bio-accumulative and toxic (PBT) or very persistent and very bio-accumulative (vPvB) in accordance with Annex XIII to Regulation (EC) No 1907/2006;

(f) active substances which are persistent organic pollutants within the meaning of Regulation (EC) No 850/2004 of the European Parliament and of the Council of 29 April 2004 on persistent organic pollutants.

2.

However, without prejudice to Article 4(1), active substances referred to in paragraph 1 may be included in Annex I [...] if it is shown that: [...]

(a) there are no suitable alternative substances or technologies; and

(b) at least one of the following conditions is met:

(i) the risk to humans or the environment from exposure to that active substance in a biocidal product, under [...] realistic worst case conditions of use, is negligible, in particular where the product is used in closed systems or strictly controlled conditions; or

(ii) [...] the active substance is essential to control a serious danger to public health or the environment; or

(iii) [...] not including the active substance in Annex I would cause disproportionate negative impacts when compared with the risk to human health or the environment arising from the use of the substance. [...]

[...]

Article 6 Data requirements for an application

1.

An application to include an active substance in Annex I shall contain at least the following elements:

(a) a dossier for the active substance satisfying the requirements set out in Annex II;

(b) a dossier satisfying the requirements set out in Annex III for at least one [...] biocidal product that contains the active substance; and

(c) if the active substance meets at least one of the exclusion criteria listed in Article 5(1), evidence that Article 5(2) is applicable.

[...]

2.

Notwithstanding paragraph 1, the applicant need not provide data required under its points (a)

and (b) where any of the following [...] applies:

(a) the data is not necessary owing to the exposure associated with the proposed uses; or

(b) it is not scientifically necessary to supply the data; or

3.

An applicant may propose to adapt the data required under paragraphs 1(a) and (b) in accordance with Annex IV. The justification for the proposed adaptations to the data requirements shall be clearly stated in the application with a reference to the specific rules in Annex IV.

[...]

4.

In order to ensure the harmonised application of paragraph 2(a), the Commission shall adopt delegated acts in accordance with Article 72a establishing criteria defining when the exposure associated with the proposed uses would justify adapting the data requirements of paragraph 1(a) and (b) as referred to in section 3 of Annex IV [...].

Article 7 Submission and validation of applications

1.

The applicant shall submit an application to include an active substance in Annex I, or to make subsequent amendments to the conditions of inclusion of an active substance, to the [...]

Agency and inform it of the name of the competent authority of the Member State that it proposes should evaluate the application. That competent authority shall be the evaluating competent authority unless, at its request, the Agency takes a decision in accordance with Article 66(2) designating another competent authority as the evaluating competent authority.

2.

The Agency shall [...] notify the evaluating competent authority without delay that the application is available in the Agency database.

The Agency shall inform the applicant of the fees payable under Article 70. It shall reject the application if the applicant fails to pay the fees within 30 days and shall inform the applicant and the evaluating competent authority accordingly.

Upon receipt of the fees payable under Article 70, the Agency shall accept the application and inform the applicant and the evaluating competent authority accordingly indicating the exact date of the acceptance.

3.

Within 30 days of the Agency accepting an application, the evaluating competent authority shall validate the application if [...] the data required in accordance with points (a) and (b) of Article 6(1) have been submitted [...].

The validation shall include a check that all the required data or justifications for the adaptation of data requirements have been submitted, but not an assessment of the quality or the adequacy of that data or such justifications [...].

4.

Where the evaluating competent authority considers that the application is incomplete, it shall inform the applicant as to what additional information is required for the validation of the application and shall set a reasonable time limit for the submission of that information. That time limit shall not normally exceed 90 days.

[...]

The evaluating competent authority shall, within 30 days of receipt of the additional information, validate the application if it determines that the additional information submitted is sufficient to comply with the requirement laid down in paragraph 3.

The evaluating competent authority shall reject the application if the applicant fails to submit the requested information within the deadline and shall inform the applicant and the Agency accordingly. In such cases, part of the fee paid [...] in accordance with Article 70 shall be reimbursed.

5.

If the evaluating competent authority considers that the application is complete it shall validate the application and shall without delay inform the applicant, the Agency and other competent authorities accordingly and indicate the exact date of the validation.

The evaluating competent authority shall make the summary of the dossier available to all other competent authorities. On request, it shall provide them with the full dossier.

6.

An appeal may be brought, in accordance with Article 67, against Agency decisions under paragraphs 1 and 2.

[...]

Article 8 Evaluation of applications

1.

The evaluating competent authority shall, within 365 days of the validation of an application, evaluate it in accordance with Articles 4 and 5, including, where relevant, any proposal to adapt data requirements submitted in accordance with Article 6(3), and send the conclusions of its evaluation to the Agency.

Prior to submitting its conclusions to the Agency, the evaluating competent authority shall provide the applicant with the opportunity to provide written [...] comments on the conclusions of the evaluation within 30 days. The evaluating competent authority shall take due account of those comments when finalising its evaluation.

[...]

2.

Where it appears that additional information is necessary to carry out the evaluation, the evaluating competent authority shall ask the applicant to submit such information within a specified time limit, and shall inform the Agency accordingly. The 365-day period referred to in paragraph 1 shall be suspended from the date of issue of the request until the date the information is received. The suspension shall not exceed 180 days in total unless it is justified by the nature of the data requested or by exceptional circumstances.
3.

Where the evaluating competent authority considers that there are concerns with regard to the cumulative effects from the use of biocidal products containing the same active substance, it shall document its concerns in accordance with the requirements of the relevant parts of Section II.3 of Annex XV to Regulation (EC) No 1907/2006 and include this as part of its conclusions.
4.

Within 270 days of receipt of the conclusions of the evaluation, the Agency shall prepare and submit to the Commission an opinion on the inclusion of the active substance in Annex I.

[...]

Article 8a Inclusion of an active substance in Annex I

In order to establish at Union level a list of active substances which may be used in biocidal products, the Commission shall, on receipt of the opinion of the Agency referred to in Article 8(4), decide, by means of a delegated act adopted in accordance with Article 72a, that an active substance shall be included in Annex I and under which conditions, or, in cases where the requirements of Article 4 are not satisfied or where the requisite information and data have not been submitted within the prescribed period, that such an active substance shall not be included in Annex I.

Article 9 Active substances which are candidates for substitution

1.

An active substance [...] shall be considered a candidate for substitution [...] if any of the following conditions are met:

(a) it meets at least one of the exclusion criteria listed in Article 5(1) and may be included in Annex I in accordance with Article 5(2);

(b) its acceptable daily intake, acute reference dose or acceptable operator exposure level, as appropriate, is significantly lower than those of the majority of the active substances included in Annex I for the same product-type and use scenario;

(c) it meets two of the criteria to be considered as a persistent, bio-accumulative and toxic substance as set out in Annex XIII of Regulation (EC) No 1907/2006;

(d) there are reasons for concern linked to the nature of the critical effects, [...] which [...]

cannot be mitigated, even with very restrictive risk management measures;

(e) it contains a significant proportion of non-active isomers or impurities.

[...]

2.

When preparing an opinion on the inclusion or renewal of the inclusion of an active substance in Annex I, the Agency shall examine whether the active substance fulfils any of the criteria listed in paragraph 1 and address the matter in its opinion.
3.

Prior to submitting the opinion on the inclusion or renewal of the inclusion of an active substance in Annex I to the Commission, the Agency shall make publicly available, without prejudice to Articles 55 and 56, information on potential candidates for substitution with a reasonable period during which relevant information, including information on available substitutes, may be submitted by interested third parties. The Agency shall take due account of the information received when finalising its opinion.
4.

By way of derogation from Article 10(3), each renewal of the inclusion in Annex I of an active substance that is considered as a candidate for substitution shall be [...] for a period not exceeding seven years.
5.

Active substances that are considered as candidates for substitution in accordance with paragraph 1 shall be identified as such in Annex I.

Article 9a Technical guidance notes

The Commission shall draw up technical guidance notes to facilitate the implementation of this Chapter, in particular Articles 5(2) and 9(1).

CHAPTER III RENEWAL AND REVIEW OF INCLUSION OF AN ACTIVE SUBSTANCE IN ANNEX I

Article 10 Conditions for renewal

1.

The Commission shall renew the inclusion of an active substance in Annex I if the active substance still meets the condition laid down in Article 4(1) and, where relevant, [...] the conditions set out in Article 5(2).
2.

In the light of scientific and technical progress, the conditions specified for the active substance referred to in Article 4(3) shall be reviewed and, where appropriate, amended.
3.

Unless otherwise specified in the decision to renew the inclusion of an active substance in Annex I, the renewal shall be for [...] fifteen years for all product-types to which the inclusion applies.

Article 11 Submission and validation of applications

1.

Applicants wishing to seek renewal of the inclusion of an active substance in Annex I for one or more product-types shall submit an application to the Agency at least 550 days before the expiry of the inclusion in Annex I [...]. Where there are different expiry dates for different product-types, the application shall be submitted at least 550 days before the earliest expiry date.

[...]

2.

When applying for the renewal of the inclusion of the active substance in Annex I, the applicant shall submit:

(a) a list of all relevant data [...] that it has generated since the initial inclusion or, as appropriate, since the previous renewal; and

(b) its assessment of whether the conclusions of the initial or previous assessment of the active substance remain valid and any supporting information.

[...]

3.

The evaluating competent authority shall be the competent authority that carried out the original evaluation unless, at its request, the Agency takes a decision in accordance with Article 66(2) designating another competent authority as the evaluating competent authority.

The Agency shall [...] notify the evaluating competent authority without delay that the application is available in the Agency database.

4.

[...] An appeal may be brought, in accordance with Article 67, against Agency decisions under [...] paragraph 3.

[...]

Article 12 Evaluation of applications for renewal

1.

On the basis of an assessment of the available information and the need to review the conclusions of the initial evaluation of the application for inclusion in Annex I or, as appropriate, the previous renewal, the evaluating competent authority [...] shall, within 90 days of the Agency accepting an application in accordance with Article 11(3), decide whether, in the light of current scientific knowledge, a full evaluation of the application for renewal is necessary taking account of all product-types for which renewal is requested.

The evaluating competent authority may at any time require the applicant to submit the data referred to in Article 11(2)(a).

2.

Where the evaluating competent authority decides that a full evaluation of the application is necessary, the evaluation shall be carried out in accordance with paragraphs 1 to 3 of Article 8. [...]

Where the evaluating competent authority decides that a full evaluation of the application is not necessary, it shall, within 180 days of the Agency accepting the application in accordance with Article 11(3), prepare and submit to the Agency a recommendation on the renewal of the inclusion of the active substance in Annex I.

[...]

3.

Within 270 days of receipt of a recommendation from the evaluating competent authority, if it has carried out a full evaluation of the application, or 90 days otherwise, the Agency shall prepare and submit to the Commission an opinion on renewal of the inclusion of the active substance in Annex I.

[...]

4.

In order to keep the list of active substances which may be used in biocidal products up-to-date, the Commission shall, [...] on receipt of the opinion of the Agency, decide on renewal of the inclusion of the active substance concerned in Annex I for one or more product-types by means of a delegated act adopted [...] in accordance with [...] Article 72a.
5.

Where, for reasons beyond the control of the applicant, the inclusion of the active substance in Annex I is likely to expire before a decision has been taken on its renewal, the Commission shall[, in accordance with the advisory procedure referred to in Article 72(2),] adopt a decision postponing the expiry date of inclusion for a period sufficient to enable it to examine the application.
6.

Where the Commission decides not to renew the inclusion of an active substance in Annex I for one or more product-types it may grant a period of grace for the disposal, [...] making available on the market and use of existing stocks of biocidal products of the product-type(s)

concerned containing that active substance.

The period of grace shall not exceed 180 days for [...] making available on the market and an additional maximum of 180 days for [...] disposal [...] and use of existing stocks of [...]

biocidal products of the product-type(s) concerned containing that active substance.

Article 13 Review of inclusion of an active substance in Annex I

1.

The Commission may review the inclusion of an active substance in Annex I for one or more product-types at any time where there are serious indications that the conditions laid down in Article 4(1) or, where relevant, 5(2) are no longer met. The Commission may also review the inclusion of an active substance in Annex I for one or more product-types at the request of a Member State if there are indications that the use of the active substance in biocidal products or treated articles raises serious concerns about the safety of such biocidal products or treated articles.

Where those indications are confirmed the Commission shall, in order to keep the list of active substances which may be used in biocidal products up-to-date, adopt a delegated act amending the inclusion of an active substance in Annex I or removing it from that Annex in accordance with Article 72a. The Commission shall inform the initial applicant(s) for the inclusion accordingly.

[...] On imperative grounds of urgency, the Commission may have recourse to the urgency procedure referred to in Article 72d.

2.

The Commission may consult the Agency on any questions of a scientific or technical nature related to the review of inclusion of an active substance in Annex I. The Agency shall, within 270 days of the request, prepare an opinion and submit it to the Commission.
3.

Where the Commission removes the entry for an active substance from Annex I, it may grant a period of grace for the disposal, [...] making available on the market and use of existing stocks of biocidal products containing that active substance.

The period of grace shall not exceed 180 days for [...] making available on the market and an additional maximum of 180 days for [...] disposal [...] and use of existing stocks of [...]

biocidal products containing that active substance.

Article 14 Implementing measures

The Commission may adopt detailed measures for the implementation of Articles 10 to 13 further specifying the procedures for the renewal and review of the inclusion of an active substance in Annex I [in accordance with the regulatory procedure [...] referred to in Article 72(3)].

CHAPTER IV GENERAL PRINCIPLES CONCERNING THE AUTHORISATION OF BIOCIDAL PRODUCTS

Article 15 Placing on the market and use of biocidal products

1.

Biocidal products shall not be placed on the market or used unless authorised in accordance with this Regulation. Once placed on the market, an authorised biocidal product may be made available on the market in accordance with that authorisation without the need for additional authorisations provided that there is no change to the biocidal product nor to its packaging and labelling.
2.

Applications for authorisation shall be made by, or on behalf of, the prospective authorisation holder [...].

Applications for national authorisation in a Member State shall be submitted to the competent authority of that Member State (hereinafter referred to as 'the receiving competent authority').

Applications for Union authorisation shall be submitted to the Agency.

3.

The authorisation holder shall be the person responsible for the placing on the market of the biocidal product in a particular Member State or in the Union.
4.

The authorisation holder shall be a legal or natural person established within the Union or shall designate, by written mandate, a person established within the Union, who shall accept in writing.
5.

An authorisation for a biocidal product may be granted for a single biocidal product or a biocidal product family.
6.

An authorisation shall be granted for a maximum period of 10 years.
7.

Biocidal products shall be used [...] in compliance with the terms and conditions of the authorisation stipulated in accordance with Article 20(1) and the labelling and packaging requirements laid down in Article 58.

Proper use shall [...] involve the rational application of a combination of physical, biological, chemical or other measures as appropriate, whereby the use of biocidal products is limited to the minimum necessary.

Article 16 Conditions for granting an authorisation

1.

A biocidal product other than those meeting the conditions laid down in Article 17(1) shall be authorised only if the following conditions are met:

(a) the active substances included therein are listed in Annex I for the relevant product-type and any conditions specified in that Annex for those active substances are met;

(b) it is established according to the common principles for the evaluation of dossiers for biocidal products laid down in Annex VI, that the biocidal product, when used as authorised and having regard to the factors referred to in paragraph 2, complies with the following criteria:

(i) it is sufficiently effective;

(ii) it has no unacceptable effects on the target organisms, in particular unacceptable resistance or cross-resistance or unnecessary suffering and pain for vertebrates;

(iii) it has no unacceptable effects itself or as a result of its residues, directly or indirectly, on human or animal health;

(iv) it has no unacceptable effects itself, or as a result of its residues, on the environment having particular regard to the following considerations:

-

its fate and distribution in the environment;
-

contamination of surface waters (including estuarial and seawater), groundwater and drinking water, air and soil;
-

its impact on non-target organisms;
-

its impact on biodiversity and the ecosystem;

(c) the nature, the quantity and the technical equivalence of active substances in the biocidal product and, where appropriate, any toxicologically or ecotoxicologically significant impurities and non-active substances, and its residues of toxicological or environmental significance, which result from uses to be authorised, can be determined according to the relevant requirements in Annexes II and III;

(d) its physical and chemical properties have been determined and deemed acceptable for purposes of the appropriate use [...] and transport of the product.

2.

The evaluation of a biocidal product against the criteria set out in point (b) of paragraph 1 shall take into account the following factors:

(a) realistic worst case conditions under which the biocidal product may be used;

(b) how any treated article treated with it or containing it may be used;

3.

[...] A biocidal product shall only be authorised for uses for which relevant information has been submitted in accordance with Article 18.
4.

A biocidal product shall not be authorised for making available on the market to, or for use by, the general public if it fulfils any of the following criteria for classification:

(a) toxic, very toxic or a category 1 or 2 carcinogen, or a category 1 or 2 mutagen or toxic for reproduction category 1 or 2 according to Directive 1999/45/EC;

(b) according to Regulation (EC) No 1272/2008:

-

acute oral toxicity category 1 or 2 or 3;
-

acute dermal toxicity category 1 or 2 or 3;
-

acute inhalation toxicity (gases and dust/mist) category 1 or 2 or 3;
-

acute inhalation toxicity (vapours) category 1 or 2;
-

category 1A or 1B carcinogen;
-

category 1A or 1B mutagen; or
-

toxic for reproduction category 1A or 1B [...].
5.

In the case of a biocidal product family, a reduction in the percentage of the active substance [...] may be allowed, and/or a variation in percentage composition of one or more non-active substances, and/or the replacement of one or more non-active substances by other specified substances presenting the same or lower risk. The classification, hazard and precautionary statements for each product within the biocidal product family shall be the same.

The biocidal product family shall be authorised if the reduction in the percentage of the active substance or the variation referred to in the first subparagraph has been evaluated and the biocidal products covered by the biocidal product family are expected to comply with the conditions set out in points (a) to (d) of paragraph 1.

6.

[...] Where appropriate, the prospective authorisation holder or its representative shall apply for the establishment of maximum residue limits with respect to active substances contained in a biocidal product in accordance with Regulation (EC) No 396/2005 of the European Parliament and of the Council and Regulation (EC) No 470/2009 of the European Parliament and of the Council .

Article 17 Simplified authorisation procedure

1.

A biocidal product shall be eligible for a simplified authorisation procedure if all the following conditions are met:

(a) all the active substances contained in the biocidal product appear in Annex IA and

-

satisfy any restriction specified in that annex;

(b) the biocidal product is not classified more severely than :

-

as irritant to the skin or to the eyes or as harmful by any route of exposure or R52/53,
-

R53 in accordance with Directive 1999/45/EC;
-

as irritant to the skin or to the eyes or as harmful by any route of exposure or aquatic
-

chronic category 3 (H412) in accordance with Regulation (EC) No 1272/2008;
*

Recitals 25 to 27 would be replaced by the following:

"(25) In order to encourage the use of products with a more favourable environmental or human health profile, it is appropriate to provide for simplified procedures for such biocidal products and to establish a specific list of the active substances that they may contain. That list should initially contain substances identified as presenting a low risk under Regulation

(EC) No 1907/2006 or Directive 98/8/EC, substances authorised as food additives, pheromones and other substances considered to have low toxicity, such as weak acids, alcohols and vegetable oils used in cosmetics and food.

(27) It is also appropriate to encourage the use of such low-risk biocidal products by providing for their free circulation throughout the Union once authorised in one Member State.".

(d) it is sufficiently effective; and

(e) the handling of the product and its intended use do not require personal protective equipment.

2.

Biocidal products eligible for a simplified procedure in accordance with paragraph 1 shall be authorised in accordance with Chapter V. During the validity of such a national authorisation in one Member State the biocidal product may be placed on the market in all other Member States without the need for mutual recognition. However, the authorisation holder shall notify each Member State before placing the biocidal product on the market within their territory and Member States may make such placing on the market conditional on the use of their official language or languages in the product's labelling.
3.

Without prejudice to Article 73, the Commission may amend Annex IA by means of a delegated act adopted in accordance with Article 72a in order:

(a) to include active substances if there is evidence that these satisfy the criteria set out in Annex IA ; or

(b) to restrict or to remove the entry for an active substance if there is evidence that biocidal products containing that substance do not satisfy the conditions set out in paragraph 1(b), (c), (d) or (e) in certain circumstances.

[...]

Article 18 Requirements for applications for authorisation

1.

The applicant for an authorisation shall submit the following documents together with the application:

(a) a dossier or letter of access for the biocidal product satisfying the requirements set out

-

in Annex III;

(b) a proposed summary of biocidal product characteristics including the information

-

referred to in points (a), (b) and (e) to (m) of Article 20(2) or (3), as applicable;

(c) for biocidal products other than biocidal products meeting the conditions laid down in Article 17(1), a dossier or a letter of access to a dossier satisfying the requirements set out in Annex II for each active substance in the biocidal product;

(d) for biocidal products that the applicant considers meet the conditions laid down in Article 17(1), any relevant information in support of that conclusion [...].

2.

[...] The receiving competent authority may require that applications for national authorisation be submitted in one or more of the official languages of the Member State where that competent authority is situated.
3.

If the application concerns a biocidal product that is intended by its manufacturer to be used also for the purposes referred to in Article 2(7), it shall be accompanied by a declaration of conformity regarding compliance with the relevant essential requirements of Directives 90/385/EEC, 93/42/EEC or 98/79/EC.

[...]

Article 19 Waiving of data requirements

1.

Notwithstanding Article 18, the applicant need not provide data required under that Article where any of the following [...] applies:

(a) the data is not necessary owing to the exposure associated with the proposed uses; or

(b) it is not scientifically necessary to supply the data; or

2.

The applicant may propose to adapt the data required under Article 18 in accordance with Annex IV. The justification for the proposed adaptations to the data requirements shall be clearly stated in the application with reference to the specific rules in Annex IV.

The competent authority shall advise the applicant about the possibility of adapting the data requirements, the grounds on which such an adaptation can be made and on how to prepare a proposal.

3.

In order to ensure the harmonised application of paragraph 1(a), the Commission shall adopt delegated acts in accordance with Article 72a establishing criteria defining when the exposure associated with the proposed uses would justify adapting the data requirements of Article 18 [...].

Article 20 Content of authorisation

1.

An authorisation shall stipulate the terms and conditions relating to the placing on the market and use of the single biocidal product or the biocidal product family and include a summary of biocidal product characteristics.
2.

The summary of biocidal product characteristics for a single biocidal product shall include the following information:

(a) trade name of the biocidal product;

(b) name and address of the authorisation holder;

(d) authorisation number;

(e) qualitative and quantitative composition in terms of the active substances and non- active substances, knowledge of which is essential for proper use of the biocidal product;

(f) manufacturers of the biocidal product (names and addresses including location of manufacturing sites);

(g) manufacturers of the active substances (names and addresses including location of manufacturing sites);

(h) physical state and nature of the biocidal product;

(i) hazard and precautionary statements;

(j) product-type [...] and target harmful organisms;

(k) application doses and instructions for use;

(l) categories of users;

(m) particulars of likely direct or indirect adverse effects and first aid instructions;

(n) instructions for safe disposal of the product and its packaging;

(o) in the case of a biocidal product that is intended by its manufacturer to be used also for the purposes referred to in Article 2(7), any specific use conditions and a statement that the biocidal product is in conformity with the relevant essential requirements of Directives 90/385/EEC, 93/42/EEC or 98/79/EC;

(p) shelf-life.

3.

The summary of biocidal product characteristics for a biocidal product family shall include the following information:

(a) trade names of the biocidal products within the biocidal product family;

(b) name and address of the authorisation holder;

(d) authorisation number together with the suffixes to apply to individual biocidal products within the biocidal product family;

(e) qualitative and quantitative composition in terms of the active substances and non-active substances, knowledge of which is essential for proper use of biocidal products within the biocidal product family. The quantitative composition shall indicate a minimum and maximum percentage for each active and non-active substance, where

-

the minimum percentage indicated for certain substances may be 0%;

(f) manufacturers of the biocidal product family (names and addresses including location of manufacturing sites);

(g) manufacturers of the active substances (names and addresses including location of manufacturing sites);

(h) physical state and nature of the biocidal products within the biocidal product family;

(i) hazard and precautionary statements;

(j) product-type and target harmful organisms;

(k) application doses and instructions for use;

(l) categories of users;

(m) particulars of likely direct or indirect adverse effects and first aid instructions;

(n) instructions for safe disposal of the product and its packaging;

(o) in the case of a biocidal product family that is intended by its manufacturer to be used also for the purposes referred to in Article 2(7), any specific use conditions and a statement that the biocidal product is in conformity with the relevant essential requirements of Directives 90/385/EEC, 93/42/EEC or 98/79/EC;

(p) shelf-life of biocidal products within the biocidal product family.

The authorisation shall require the holder to notify the competent authority of each product within the biocidal product family to be placed on the market, indicating the trade name and suffix to the authorisation number.

[...]

Article 21 Comparative assessment of biocidal products

1.

The receiving competent authority or, in the case of evaluation of an application for a Union authorisation, the evaluating competent authority, shall perform a comparative assessment as part of the evaluation of an application for authorisation or for renewal of authorisation of a biocidal product containing an active substance that is a candidate for substitution in accordance with Article 9(1).
2.

The results of the comparative assessment shall be forwarded, without delay, to the competent authorities of other Member States and the Agency and, in the case of evaluation of an application for a Union authorisation, also to the Commission.
3.

The receiving competent authority or, in the case of a decision on an application for a Union authorisation, the Commission shall prohibit or restrict the making available on the market or use of a biocidal product containing an active substance that is a candidate for substitution where the comparative assessment weighing up the risks and benefits in accordance with Annex VI demonstrates that all the following criteria are met:

(a) for the uses specified in the application, another authorised biocidal product or a non- chemical control or prevention method already exists which presents a significantly lower overall risk for human and animal health and the environment and no [...]

significant economic or practical disadvantages, including insufficient efficacy;

(b) the chemical diversity of the active substances is adequate to minimise the occurrence of resistance in the target harmful organism.

4.

By way of derogation from paragraph 1, a biocidal product containing an active substance that is a candidate for substitution may be authorised for a period of up to two years without comparative assessment in exceptional cases where it is necessary to acquire experience first through using that product in practice.
5.

Where the comparative assessment involves a question which, by reason of its scale or consequences, would be better addressed at Union level, in particular where it is relevant to two or more competent authorities, the receiving competent authority may refer the question to the Commission for a decision. The Commission shall adopt the decision [in accordance with the regulatory procedure referred to in Article 72(3)].

The Commission shall adopt a delegated act in accordance with Article 72a specifying when comparative assessments involve questions better addressed at Union level and the procedures for such comparative assessments [...].

6.

Notwithstanding Article 15(4), an authorisation for a biocidal product containing an active substance that is a candidate for substitution shall be granted for a period not exceeding five years.
7.

Where it is decided not to authorise or to restrict the use of a biocidal product pursuant to paragraph 3, that cancellation or amendment of the authorisation shall take effect [three]

[five] years after that decision. However, where the inclusion in Annex I of the active substance which is a candidate for substitution expires on an earlier date, the cancellation of the authorisation shall take effect on that earlier date.

Article 21a Technical guidance notes

The Commission shall draw up technical guidance notes to facilitate the implementation of this

Chapter and, in particular, Articles 18(1)(d), 20(3) and 21(3).

CHAPTER V NATIONAL AUTHORISATIONS OF BIOCIDAL PRODUCTS

Article 22 Submission and validation of applications

1.

Applicants wishing to apply for a national authorisation in accordance with Article 15 shall submit an application to the receiving competent authority. The receiving competent authority shall inform the applicant of the fees payable in accordance with Article 70. It shall reject the application if the applicant fails to pay the fees within 30 days and shall inform the applicant accordingly. Upon receipt of the fees payable under Article 70, the receiving competent authority shall accept the application and inform the applicant indicating the exact date of the acceptance.
2.

Within 30 days of acceptance [...] , the receiving competent authority shall validate the application if it complies with the following requirements:

(a) the relevant information referred to in Article 18 has been submitted;

(b) the applicant states that it has not applied to any other competent authority for a national authorisation for the same biocidal product for the same use(s).

[...]

The validation shall [...] include a check that all the required data or justifications for the adaptation of data requirements have been submitted, but not an assessment of the quality or the adequacy of that data or such justifications [...].

3.

Where the receiving competent authority considers that the application is incomplete, it shall inform the applicant as to what additional information is required for the validation of the application and shall set a reasonable time limit for the submission of that information. That time limit shall not normally exceed 90 days.

The receiving competent authority shall, within 30 days of receipt of the additional information, validate the application if it determines that the additional information submitted is sufficient to comply with the requirements laid down in paragraph 1.

The receiving competent authority shall reject the application if the applicant fails to submit the requested information within the deadline and shall inform the applicant accordingly.

4.

Where the [...] Register for Biocidal Products shows that a competent authority other than the receiving competent authority is examining an application relating to the same biocidal product or has already authorised the same biocidal product, the receiving competent authority shall decline to evaluate the application. In that event, the receiving competent authority shall inform the applicant of the possibility of seeking mutual recognition in accordance with Article 25 or 26.
5.

If paragraph 3 does not apply and the receiving competent authority [...] considers that the application is complete, it shall validate the application and without delay inform the applicant accordingly and indicate the date of the validation.

Article 23 Evaluation of application

1.

The receiving competent authority shall, within 365 days of the validation of an application in accordance with Article 22, decide whether to grant an authorisation in accordance with Article 16 and, if applicable, Article 17. It shall take into account the results of the comparative assessment carried out in accordance with Article 21, if applicable.

[...]

2.

Where it appears that additional information is necessary to carry out the evaluation, the receiving competent authority shall ask the applicant to submit such information within a specified time limit. The 365-day period referred to in paragraph 1 shall be suspended from the date of issue of the request until the date the information is received. The suspension shall not exceed 180 days in total unless it is justified by the nature of the data requested or by exceptional circumstances.

The receiving competent authority shall reject the application if the applicant fails to submit the requested information within the deadline and shall inform the applicant accordingly.

3.

Within the 365-day period referred to in paragraph 1, the receiving competent authority shall:

(a) draft a report summarising the conclusions of its assessment and the reasons for authorising the biocidal product or for refusing to grant an authorisation (hereinafter referred to as the 'assessment report');

(b) send an electronic copy of the draft assessment report to the applicant and provide it with the opportunity to submit [...] comments within 30 days; and

4.

Where the receiving competent authority decides to grant an authorisation it shall enter the following information in the [...] Register for Biocidal Products:

(a) the summary of biocidal product characteristics referred to in Article 20(2) or (3), as applicable;

(b) the final assessment report;

Where the receiving competent authority decides not to grant an authorisation it shall enter the final assessment report in the Register for Biocidal Products.

It either case, it shall notify the applicant of its decision together with a copy of the final assessment report.

Article 24 Renewal of a national authorisation

1.

An application by or on behalf of an authorisation holder [...] wishing to seek the renewal of a national authorisation for one or more product-types shall be submitted to the receiving competent authority at least 550 days before the expiry date of the authorisation. Where renewal is sought for more than one product-types, the application shall be submitted at least 550 days before the earliest expiry date.

[...]

2.

The receiving competent authority shall renew the national authorisation, provided that the conditions set out in Article 16 and, if applicable Article 17, are still satisfied. It shall take into account the results of the comparative assessment carried out in accordance with Article 21, if applicable.
3.

When applying for renewal, the applicant shall submit:

(a) a list of all relevant data [...] that it has generated since the initial authorisation or, as appropriate, previous renewal; and

(b) its assessment of whether the conclusions of the initial or previous assessment of the biocidal product remain valid and any supporting information.

[...]

4.

[...] The receiving competent authority shall inform the applicant of the fees payable in accordance with Article 70. It shall reject the application if the applicant fails to pay the fees within 30 days and shall inform the applicant accordingly.

Upon receipt of the fees payable under Article 70, the receiving competent authority shall accept the application and [...] inform the applicant accordingly indicating the date of the acceptance.

5.

The decision whether to renew the national authorisation shall be taken within 180 days of the receiving competent authority accepting it.
6.

Where, when the application for renewal is evaluated, it appears that additional information is necessary to carry out the evaluation [...], the receiving competent authority shall ask the applicant to submit such information within a specified time limit. The 180-day period referred to in paragraph 6 shall be suspended from the date of the request until the date the information is received. The suspension shall not exceed 180 days in total unless it is justified by the nature of the data requested or by exceptional circumstances. The receiving competent authority shall reject the application if the applicant fails to submit the requested information within the deadline and shall inform the applicant accordingly.

The receiving competent authority may at any time require the applicant to submit the data referred to in paragraph 3(a).

7.

The receiving competent authority shall draft a report summarising the conclusions of its assessment and the reasons for renewing the authorising the biocidal product or for refusing to renew the authorisation (hereinafter referred to as the 'assessment report'). The receiving competent authority shall send the draft assessment report to the applicant and provide it with the opportunity to submit written comments within 30 days. The receiving competent authority shall take due account of those comments when finalising its assessment.
8.

Where, for reasons beyond the control of the holder of a national authorisation, no decision is taken on the renewal of that authorisation before its expiry, the receiving competent authority shall grant a renewal [...] for the period necessary to complete the evaluation.
9.

As soon as the competent authority has taken a decision on whether to grant a renewal of a national authorisation, it shall update the information referred to in Article 23(4) in the [...]

Register for Biocidal Products. It shall notify the applicant of its decision together with a copy of the final assessment report.

CHAPTER VI MUTUAL RECOGNITION PROCEDURES

Article 24a Authorisation through mutual recognition

1.

Applications for mutual recognition of a national authorisation shall be made by the authorisation holder as defined in Article 15(3) or another person designated in accordance with Article 15(4). They shall be made in accordance with the procedures set out in Articles 25 (mutual recognition in sequence) or 26 (mutual recognition in parallel).
2.

Without prejudice to Article 29, all Member States receiving applications for mutual recognition of a national authorisation shall, in accordance with and subject to the procedures set out in this Chapter, authorise the biocidal product under the same terms and conditions.

Article 25 Mutual recognition [...] in sequence

1.

Applicants wishing to seek the mutual recognition in sequence in one or more Member States (for the purposes of this Article, 'the Member States concerned') of the national authorisation of a biocidal product already granted in another Member State in accordance with Article 15 (hereinafter referred to as 'the reference Member State') shall submit an application to the competent authorities of the Member States concerned containing:

(a) [...] translations, into such official languages of the Member States concerned as they may require, of the national authorisation granted by the reference Member State; and

(b) an electronic summary of the dossier satisfying the requirements set out in Annex III or, at the request of any of the competent authorities of the Member States concerned, the actual study reports for all studies submitted if not already available via the Register for Biocidal Products. [...]

[...]

The competent authorities of the Member States concerned shall inform the applicant of the fees payable in accordance with Article 70. They shall reject the application if the applicant fails to pay the fees within 30 days and shall inform the applicant and the other competent authorities accordingly. Upon receipt of the fees payable under Article 70, the competent authority of the Member States concerned shall accept the application and inform the applicant indicating the exact date of acceptance.

2.

Within 30 days of acceptance referred to in paragraph 1, the Member States concerned shall validate the application and inform the applicant accordingly indicating the date of the validation.

Within 90 days of validating the application, and subject to Articles 27, 28 and 29, the Member States concerned shall agree the summary of biocidal product characteristics and shall record their agreement in the [...] Register for Biocidal Products.

3.

The procedure shall be closed after all the Member States concerned have agreed the summary of biocidal product characteristics and recorded their agreement in the [...] Register for Biocidal Products.
4.

Upon closure of the procedure, each of the concerned Member States shall adopt a decision in conformity with the agreed summary of biocidal product characteristics within 30 days.

[...]

Article 26 Mutual recognition [...] in parallel

1.

Applicants wishing to seek the mutual recognition in parallel of a biocidal product not authorised in accordance with Article 15 in any Member State [...] shall submit to the competent authority of the Member State of its choice (hereinafter referred to as 'the reference Member State') an application containing:

(a) the information referred to in Article 18;

(b) a list of all other Member States where a national authorisation is sought (for the purposes of this Article, 'the Member States concerned').

[...]

The reference Member State shall be responsible for the evaluation of the application.

2.

The applicant shall, at the same time as submitting the application in accordance with paragraph 1, submit to the competent authorities of each of the Member States concerned an application for mutual recognition of the authorisation for which it has applied to the reference Member State. This application shall contain:

(a) an electronic summary of the dossier as required in Annex III;

(b) the names of the reference Member State and of the Member States concerned;

in such official languages of the Member States concerned as they may require.

[...]

3.

The competent authorities of the reference Member State and of the Member States concerned shall inform the applicant of the fees payable in accordance with Article 70. They shall reject the application if the applicant fails to pay the fees within 30 days and shall inform the applicant and the other competent authorities accordingly. Upon receipt of the fees payable under Article 70, the competent authorities of the reference Member State and of the Member States concerned shall accept the application and inform the applicant accordingly indicating the date of acceptance.
4.

The reference Member State shall [...] validate the application in accordance with Article 22(2) and (3) and inform the applicant and the Member States concerned accordingly.

Within 365 days of validating an application, the reference Member State shall evaluate the application and draft an assessment report in accordance with Article 23(3) and (4) and shall send its assessment report and the summary of biocidal product characteristics to the Member States concerned and to the applicant.

5.

Within 90 days of receipt of the documents referred to in the paragraph 4, and subject to Articles 27, 28 and 29, the [...] Member States concerned shall agree the summary of biocidal product characteristics, and shall record their agreement in the [...] Register for Biocidal Products.
6.

The procedure shall be closed after all the Member States concerned have agreed the summary of biocidal product characteristics and recorded their agreement in the [...] Register for Biocidal Products.
7.

Upon closure of the procedure, the reference Member State and each Member State concerned shall adopt a decision in conformity with the agreed summary of biocidal product characteristics within 30 days.

[...]

Article 27 Referral of objections to the coordination group

1.

A coordination group shall be set up to examine any question, other than matters referred to in Article 29, relating to whether a biocidal product for which an application for mutual recognition has been made in accordance with Article 25 or 26 meets the conditions for granting an authorisation laid down in Article 16.

All Member States shall be entitled to participate in the work of the coordination group.

The coordination group shall establish its rules of procedure.

2.

If, within the 90-day period laid down in Articles 25(2) and 26(5), any of the Member States concerned considers that a biocidal product authorised by the reference Member State does not meet the conditions laid down in Article 16, it shall send a detailed explanation of the points of disagreement and the reasons for its position to the reference Member State, the other Member States concerned, the applicant, and, where applicable, the authorisation holder. The points of disagreement shall be referred without delay to the coordination group.
3.

Within the coordination group, all Member States referred to in paragraph 2 shall use their best endeavours to reach agreement on the action to be taken. They shall allow the applicant the opportunity to make its point of view known. Where they reach agreement within 60 days of the communication referred to in paragraph 2, the reference Member State shall record the agreement in the [...] Register for Biocidal Products. The procedure shall then be considered to be closed and Article 25(4) or 26(7) shall apply as appropriate.

Article 28 Referral of unresolved objections to the Commission

1.

If Member States fail to reach agreement within the 60-day period laid down in Article 27(3), the reference Member State shall immediately inform the Commission, and provide it with a detailed statement of the matters on which Member States have been unable to reach agreement and the reasons for their disagreement. A copy shall be forwarded to the Member States concerned, the applicant and, where applicable, the authorisation holder.
2.

The Commission may ask the Agency for an opinion on scientific or technical questions raised by Member States. Where the Commission does not ask the Agency for an opinion it shall provide the applicant and, where applicable, the authorisation holder with the opportunity to provide written comments within 30 days.
3.

The Commission shall consider and adopt a decision on the matter referred to it [in accordance with the regulatory procedure referred to in Article 72(3)].
4.

The decision referred to in paragraph 3 shall be addressed to all Member States and reported for information to the applicant and, where applicable, the authorisation holder. The Member States concerned and the reference Member State shall, within 30 days of notification of the decision, either grant, refuse to grant or revoke the authorisation, or vary its terms and conditions as necessary to comply with the decision.

Article 29 Derogations from mutual recognition

1.

By way of derogation from Article 24a(2), any of the Member States concerned may propose to refuse to grant an authorisation or to adjust the terms and conditions of the authorisation to be granted, provided that such a measure can be justified on grounds of:

(a) the protection of the environment;

(b) public policy or public security;

(d) the protection of national treasures possessing artistic, historic or archaeological value.

2.

The Member State concerned shall communicate to the applicant a detailed statement of the grounds for seeking a derogation on the grounds referred to in paragraph 1 and shall seek to reach an agreement with the applicant on the proposed derogation.

If the Member State concerned is unable to reach agreement with the applicant it shall inform the Commission within 60 days of that communication. In that case, the Commission:

(a) may ask the Agency for an opinion on scientific or technical questions raised by the applicant or the Member State concerned;

(b) shall adopt a decision on the derogation [in accordance with the regulatory procedure referred to in Article 72(3)].

The decision shall be addressed to the Member State concerned and reported for information to the applicant.

The Member State concerned shall take necessary measures to comply with the decision within 30 days of its notification.

3.

By way of derogation from Article 24a(2), a Member State may refuse to grant authorisations for product-types 15, 17 and 23 [...] on grounds of animal welfare. Member States shall without delay inform other Member States and the Commission of any decision taken in this respect and its justification.

Article 30 Opinion of the Agency

1.

If so requested by the Commission pursuant to Article 28(2) or 29(2), the Agency shall issue an opinion within 120 days from the date on which the matter was referred to it.
2.

Before issuing its opinion, the Agency shall provide the applicant and, where applicable, the authorisation holder with an opportunity to present [...] explanations within a specified time limit not exceeding 30 days.

The Agency may suspend the time limit referred to in paragraph 1 to allow the applicant or the authorisation holder to prepare the explanations.

Article 31 Application for mutual recognition by pest control bodies

1.

Where no application for a national authorisation has been submitted in a Member State for a biocidal product that is already authorised in another Member State, official or scientific bodies involved in pest control activities or the protection of public health may apply, under the mutual recognition procedure provided for in Article 25 and with the consent of the authorisation holder in the other Member State, for a national authorisation for the same biocidal product, with the same use and the same conditions for use as in that Member State.

The applicant shall demonstrate that the use of such a biocidal product is of general interest for pest control in that Member State.

The application shall be accompanied by the fees payable under Article 70.

2.

[...] If the competent authority of the Member State concerned considers that the biocidal product fulfils the conditions referred to in Article 16 and the conditions under this Article are met, the competent authority shall authorise the placing on the market and use of the biocidal product. [...] In that case, the body that made the application shall have the same rights and obligations as other authorisation holders.

Article 31a Detailed rules and technical guidance notes

In order to ensure a harmonised approach, the Commission shall adopt a delegated act in

accordance with Article 72a in order to establish detailed rules for the renewal of authorisations subject to mutual recognition.

The Commission shall also draw up technical guidance notes to facilitate the implementation of this Chapter and, in particular, Articles 29 and 31.

CHAPTER VII UNION AUTHORISATIONS OF BIOCIDAL PRODUCTS Section 1 Granting of Union authorisations

Article 32 Union authorisation

A Union authorisation issued by the Commission in accordance with this Section shall be valid throughout the Union unless otherwise specified. It shall confer the same rights and obligations in each Member State as a national authorisation. For those categories of biocidal products referred to in Article 33(1), the applicant may apply for Union authorisation as an alternative to applying for a national authorisation and mutual recognition.

Article 33 Biocidal products for which Union authorisation may be granted

Applicants may apply for Union authorisation for the following categories of biocidal products:

[...]

(1) biocidal products of product-types 6, 7, 9, 10, 12, 13 and 22; and

(2) with effect from 1 January [2020], all other biocidal products except for those of product-types 14, 15, 17, 21 and 23,

provided that they have similar conditions of use across the Union.

[...]

Should more time be necessary to make preparations for the widening of the scope of the Union authorisation procedure to further product-types provided for in point (2) above, the Commission may adopt a delegated act in accordance with Article 72a in order to postpone the date provided for in point 2 for some or all products-types.

Article 34 Submission and validation of applications

1.

Applicants wishing to apply for Union authorisation in accordance with Article 33(1) shall submit an application to the Agency and inform it of the name of the competent authority of the Member State that they propose should evaluate the application. That competent authority shall be the evaluating competent authority unless, at its request, the Agency takes a decision in accordance with Article 66(2) designating another competent authority as the evaluating competent authority.
2.

The Agency shall [...] notify the evaluating competent authority without delay that the application is available in the Agency database.

Upon receipt of the fees payable under Article 70, the Agency shall accept the application and inform the applicant and the evaluating competent authority accordingly.

3.

Within 30 days of the Agency accepting an application, the evaluating competent authority shall validate the application if [...] the relevant information referred to in Article 18 has been submitted [...].

4.

Where the evaluating competent authority considers that the application is incomplete, it shall inform the applicant as to what additional information is required for the evaluation of the application and shall set a reasonable time limit for the submission of that information. That time limit shall not normally exceed 90 days.

[...]

The evaluating competent authority shall reject the application if the applicant fails to submit the requested information within the deadline and shall inform the applicant [...] accordingly.

In such cases, part of the fee paid [...] in accordance with Article 70 shall be reimbursed.

5.

[...] If, after receiving the required information, the evaluating competent authority considers that the application is complete it shall validate the application and shall without delay inform the applicant, the Agency and other competent authorities accordingly and indicate the exact date of the validation.

The evaluating competent authority shall make the summary of the dossier available to all other competent authorities. On request, it shall provide them with the full dossier.

6.

An appeal may be brought, in accordance with Article 67, against Agency decisions under [...] paragraphs 1 and 2.

Article 35 Evaluation of applications

1.

The evaluating competent authority shall, within 365 days of the validation of an application, evaluate it in accordance with Article 16, including, where relevant, any proposal to adapt data requirements submitted in accordance with Article 19(2), and send the conclusions of its evaluation to the Agency.

[...]

2.

Where it appears that additional information is necessary to carry out the evaluation, the evaluating competent authority shall ask the applicant to submit such information within a specified time limit, and shall inform the Agency accordingly. The 365-day period referred to in paragraph 1 shall be suspended from the date of issue of the request until the date the information is received. However, the suspension shall not exceed 180 days in total other than in exceptional cases and where justified by the nature of the data requested.
3.

Within 180 days of receipt of the conclusions of the evaluation, the Agency shall prepare and submit to the Commission an opinion on the authorisation of the biocidal product.

If the Agency recommends the authorisation of the biocidal product, the opinion shall contain at least the following elements:

(a) a statement on whether the conditions [...] laid down in Article 16(1) are fulfilled, and a draft summary of biocidal product characteristics, as referred to in Article 20(2) or (3), as applicable;

(b) where relevant, details of any terms or conditions which should be imposed on the placing on the market or use of the biocidal product;

4.

On receipt of the opinion of the Agency, the Commission shall adopt a decision on the Union authorisation of the biocidal product [in accordance with the regulatory procedure referred to in Article 72(3)]. As soon as the Commission has taken a decision to grant a Union authorisation, it shall enter the information referred to in Article 23(4) in the [...] Register for Biocidal Products.

The Commission may, at the request of a Member State, decide [...] to adjust certain conditions of a Union authorisation [...] specifically for the territory of that Member State or that a Union authorisation shall not apply in the territory of that Member State, provided that such a request can be justified on one or more of the grounds referred to in Article 29(1).

[...]

Section 2 Renewal of Union authorisations

Article 36 Submission and validation of applications

1.

An application by or on behalf of an authorisation holder [...] wishing to seek the renewal of

a Union authorisation shall be submitted to the Agency at least 550 days before the expiry date of the authorisation.

The application shall be accompanied by the fees payable under Article 70.

2.

When applying for renewal, the applicant shall submit:

(a) a list of all relevant data [...] that it has generated since the initial authorisation or, as appropriate, previous renewal; and

(b) its assessment of whether the conclusions of the initial or previous assessment of the active substance remain valid and any supporting information.

3.

The evaluating competent authority shall be the competent authority that carried out the original evaluation unless, at its request, the Agency takes a decision in accordance with Article 66(2) designating another competent authority as the evaluating competent authority.

The Agency shall [...] notify the evaluating competent authority without delay that the application is available in the Agency database.

Upon receipt of the fees payable under Article 70, the Agency shall accept the application and inform the applicant and the evaluating competent authority accordingly.

[...]

4.

[...] An appeal may be brought, in accordance with Article 67, against Agency decisions under [...] paragraph 3.

[...]

Article 37 Evaluation of applications for renewal

1.

On the basis of an assessment of the available information and the need to review the conclusions of the initial assessment of the application for Union authorisation or, as appropriate, the previous renewal, the evaluating competent authority [...] shall, within 30 days of the Agency accepting the application in accordance with Article 36(5), decide whether, in the light of current scientific knowledge, a full evaluation of the application for renewal is necessary.

The evaluating competent authority may at any time require the applicant to submit the data referred to in Article 36(2)(a).

2.

Where the evaluating competent authority decides that a full evaluation of the application is necessary, the evaluation shall be carried out in accordance with paragraphs 1 to 3 of Article 35. [...]

Where the evaluating competent authority [...] decides that a full evaluation of the application is not necessary, it shall, within 180 days of the validation, prepare and submit to the Agency a recommendation on the renewal of the authorisation.

[...]

3.

Within 180 days of receipt of a recommendation from the evaluating competent authority, the Agency shall prepare and submit to the Commission an opinion on the renewal of the Union authorisation. [...]
4.

[...] On receipt of the opinion of the Agency, the Commission shall adopt a decision to renew, or to refuse to renew, the Union authorisation [in accordance with the regulatory procedure referred to in Article 72(3)]. As soon as the Commission has taken a decision, it shall update the information referred to in Article 23(4) in the [...] Register for Biocidal Products.

The Commission shall renew a Union authorisation, provided that the conditions set out in Article 16 are still satisfied.

5.

Where, for reasons beyond the control of the holder of the Union authorisation, no decision is taken on the renewal of the authorisation before its expiry, the Commission shall grant the renewal of the Union authorisation for the period necessary to complete the evaluation [in accordance with the advisory procedure referred to in Article 72(2)].

CHAPTER VIII CANCELLATION, REVIEW AND AMENDMENT OF AUTHORISATIONS

Article 38 Obligation for notification of new information

1.

On becoming aware of information concerning the authorised biocidal product, or the active substance(s) it contains, which may affect the authorisation the holder of an authorisation shall without delay notify the competent authority that granted the national authorisation and the Agency or, in the case of a Union authorisation, the Commission and the Agency. In particular, the following shall be notified:

(a) new data or information on the adverse effects of the active substance or biocidal product for humans or the environment;

(b) any data indicating the potential of the active substance for the development of resistance;

2.

The competent authority that granted the national authorisation or in the case of a Union authorisation, the Agency, shall examine whether the authorisation needs to be amended or cancelled in accordance with Article 39.
3.

The competent authority that granted the national authorisation or in the case of a Union authorisation, the Agency, shall without delay notify competent authorities of other Member States and, where appropriate, the Commission of any such data or information it receives.

Competent authorities of Member States that have issued national authorisations for the same biocidal product under the mutual recognition procedure shall examine whether the authorisation needs to be amended or cancelled in accordance with Article 39.

4.

The authorisation holder shall notify each competent authority having granted a national authorisation for a biocidal product family of each product within the biocidal product family before placing it on the market. The notification shall indicate the exact composition, trade name and suffix to the authorisation number. In the case of a Union authorisation, the authorisation holder shall notify the Agency and the Commission.

Article 39 Cancellation or amendment of an authorisation

1.

Without prejudice to Article 21, the competent authority of a Member State or, in the case of a Union authorisation, the Commission, shall at any time cancel or amend an authorisation it has granted if it considers that:

(a) the requirements referred to in Article 16 are not satisfied;

(b) the authorisation was granted on the basis of false or misleading information [...];

2.

Where the competent authority or, in the case of a Union authorisation, the Commission, intends to cancel or amend an authorisation, it shall inform the authorisation holder thereof and give it the opportunity to submit [...] comments or additional information within a specified time limit. The evaluating competent authority or, as appropriate, the Commission shall take due account of those comments when finalising its decision.
3.

Where the competent authority or, in the case of a Union authorisation, the Commission, cancels or amends an authorisation in accordance with paragraph 1, it shall without delay notify the authorisation holder, the competent authorities of other Member States and, where relevant, the Commission.

Competent authorities that have issued authorisations [...] under the mutual recognition procedure for biocidal products for which the authorisation has been cancelled or amended shall, within 120 days, cancel or amend the authorisations accordingly, taking into account local circumstances, and shall notify the Commission accordingly.

In the case of disagreement between competent authorities of certain Member States concerning national authorisations subject to mutual recognition [...] the procedures laid down in Articles 27 and 28 shall apply mutatis mutandis.

4.

As soon as the competent authority or the Commission in the case of a Union authorisation, has taken a decision to cancel or amend an authorisation, it shall update the information referred to in Article 23(5) relating to the biocidal product concerned in the [...] Register for Biocidal Products.

Article 40 Cancellation of an authorisation at the request of the authorisation holder

At the reasoned request of an authorisation holder, the competent authority that granted the national authorisation or, in the case of Union authorisation, the Commission, shall cancel the authorisation [...]. Where such a request concerns a Union authorisation, it shall be submitted to the Agency.

As soon as the competent authority, or the Commission in the case of a Union authorisation, has taken a decision to cancel an authorisation, it shall update the information referred to in Article 23(5) relating to the biocidal product concerned in the [...] Register for Biocidal Products.

Article 41 Amendment of an authorisation at the request of the authorisation holder

1.

Changes to the terms and conditions of an authorisation shall be made only by the competent authority that authorised the biocidal product concerned, or in the case of a Union authorisation, by the Commission.
2.

An application by an authorisation holder to amend the terms and conditions of an authorisation shall be submitted to the competent authorities of all relevant Member States having authorised the biocidal product concerned, or in the case of a Union authorisation, to the Agency.

The application shall be accompanied by the fees payable under Article 70.

Article 42 Detailed rules

In order to ensure the harmonised approach to the cancellation and amendment of authorisations, the Commission shall adopt a delegated act in accordance with Article 72a specifying the criteria and procedures for the application of Articles 39 to 41, including a dispute settlement mechanism [...].

Article 43 Period of grace

Notwithstanding Article 77, where the competent authority or, in the case of a biocidal product authorised at Union level, the Commission, cancels or amends an authorisation or decides not to renew it, it shall grant a period of grace for the disposal, [...] making available on the market and use of existing stocks, except in cases where continued making available on the market or use of the product would constitute an unacceptable risk to human health or the environment.

The period of grace shall not exceed 180 days for the making available on the market and an additional maximum period of 180 days for the disposal [...] and use of existing stocks of the biocidal products concerned.

CHAPTER VIIIA PARALLEL TRADE

Article 44 Parallel trade

1.

A competent authority of a Member State (hereinafter referred to as 'Member State of introduction') shall, at the request of the applicant, grant a parallel trade permit for a biocidal product that is authorised in another Member State (hereinafter referred to as 'Member State of origin') to be made available on the market and used in the Member State of introduction, if it determines that the biocidal product is [...] identical in composition to a biocidal product already authorised in the Member State of introduction (hereinafter referred to as 'the reference product').

The applicant who intends to place the biocidal product on the market in the Member State of introduction shall submit the application for a parallel trade permit to the competent authority of the Member State of introduction.

The application shall be accompanied by the information referred to in paragraph 4 and all other information necessary to demonstrate that the biocidal product is [...] identical to the reference product as defined in paragraph 3.

2.

Where the competent authority of the Member State of introduction determines that a biocidal product is identical to the reference product, it shall grant a parallel trade permit [...] within 60 days of receipt of the fees payable under Article 70. The competent authority of the Member State of introduction may request from the competent authority of the Member State of origin additional information necessary to determine whether the product is [...] identical to the reference product. The competent authority of the Member State of origin shall provide the requested information within 30 days of receiving the request.
3.

A biocidal product shall be considered as [...] identical to the reference product if, and only if, all the following conditions are met:

(a) they have been manufactured by the same company or by an associated undertaking or under license in accordance with the same manufacturing process;

(b) they are identical in specification and content to the active substances and the type of formulation; and

(d) they are either the same or equivalent in packaging size, material or form, in terms of the potential adverse impact on the safety of the product with regard to human or animal health or the environment.

4.

An application for a parallel trade permit shall include the following information and items:

(a) name and authorisation number of the biocidal product in the Member State of origin;

(b) name and address of the competent authority of the Member State of origin [...];

(d) original label and instructions for use with which the biocidal product is distributed in the Member State of origin if it is considered as necessary for the examination by the competent authority of the Member State of introduction;

(e) name and address of the applicant;

(f) name to be given to the biocidal product to be distributed in the Member State of introduction;

(g) a draft label for the product intended to be placed on the market in the Member State of introduction in the official language or languages of the Member State of introduction, unless that Member State provides otherwise;

(h) a sample of the product which is intended to be introduced if it is considered as

-

necessary by the competent authority of the Member State of introduction;

(i) name and authorisation number of the reference product in the Member State of introduction.

The competent authority of the Member State of introduction may require a translation of the relevant parts of the original instructions for the use referred to in point (d).

5.

The parallel trade permit shall prescribe the same conditions for making available on the market and use as the authorisation of the reference product.
6.

The parallel trade permit shall be valid for the duration of authorisation of the reference product in the Member State of introduction.

If the authorisation holder of the reference product applies for cancellation of authorisation in accordance with Article 40 and the requirements of Article 16 are still fulfilled, the validity of the parallel trade permit shall expire on the date on which the authorisation of the reference product would have normally expired.

7.

Without prejudice to specific provisions in this Article, Articles 38 to 41 and Chapter XII shall apply mutatis mutandis to biocidal products made available on the market under a parallel trade permit.
8.

The competent authority of the Member State of introduction may withdraw a parallel trade permit if the authorisation of the introduced biocidal product is withdrawn in the Member State of origin because of safety or efficacy reasons.
9.

Where a decision concerning the application for a parallel trade permit is taken in accordance with the provisions of this Article, the competent authorities of Member States which have taken such a decision shall enter the information referred to in Article 23(4) in the [...]

CHAPTER IX DEROGATIONS

Article 45 Derogation from the requirements

1.

By way of derogation from Articles 15 and 16, a competent authority may permit, for a period not exceeding 270 days, the making available on the market of a biocidal product not complying with the provisions of this Regulation for a limited and controlled use if such a measure is necessary because of a danger to public health or the environment which cannot be contained by other means.

The competent authority referred to in the first subparagraph shall without delay inform the other competent authorities and the Commission of its action and the justification for it. The competent authority shall without delay inform the other competent authorities and the Commission of the revocation of such action.

On reasoned request of the competent authority, the Commission shall without delay decide whether, and under what conditions, the action taken by that competent authority may be extended for a period not exceeding 550 days [in accordance with the regulatory procedure referred to in Article 72(3)].

2.

By way of derogation from point (a) Article 16(1) and until an active substance is listed in Annex I, competent authorities and the Commission may authorise, for a period not exceeding three years, the making available on the market of a biocidal product containing a new active substance not listed in Annex I.

Such a provisional authorisation may be issued only if, after dossiers have been evaluated in accordance with Article 8, the evaluating competent authority has submitted a recommendation for inclusion of the new active substance in Annex I and the competent authority which received the application for the provisional authorisation or, in case of Union authorisation, the Agency, considers that the biocidal product may be expected to comply with points (b), (c) and (d) of Articles 16(1).

The competent authorities or the Commission shall enter the information [...] referred to in Article 23(4) in the [...] Register for Biocidal Products.

If the Commission decides not to include the new active substance in Annex I, the competent authority which granted the provisional authorisation [...] or the Commission shall cancel that authorisation.

Where a decision on the inclusion of the new active substance in Annex I has not yet been adopted by the Commission when the period of three years expires, the competent authority which granted the provisional authorisation, or the Commission, may extend the provisional authorisation for a period not exceeding one year, provided that there are good reasons to believe that the active substance will satisfy the requirements of Article 4. Competent authorities which extend the provisional authorisation shall inform the other competent authorities and [...] the Commission of such action.

3.

In addition to the active substances referred to in Article 15(2) of Regulation (EC)

No 1907/2006, active substances manufactured or imported for use in biocidal products which are authorised for making available on the market in accordance with this Article shall be regarded as being registered and the registration as completed for manufacture or import for the use in a biocidal product and therefore as fulfilling the requirements of Chapters 1 and 5, Title II of Regulation (EC) No 1907/2006.

Article 46 Research and development

1.

By way of derogation from Article 15, an experiment or a test for the purposes of research or development involving the making available on the market or use of an unauthorised biocidal product or an active substance intended exclusively for use in a biocidal product may take place only in the case of scientific research and development or product and process-orientated research and development, and under the conditions laid down in the second and third subparagraphs.

Any person intending to carry out such an experiment or test shall first notify the relevant competent authority [...] of the Member State where the experiment or test will occur. They shall draw up and maintain written records detailing the identity of the biocidal product or active substance, labelling data, quantities supplied and the names and addresses of those persons receiving the biocidal product or active substance, and shall compile a dossier containing all available data on possible effects on human or animal health or impact on the environment. They shall [...] make this information available to the competent authority on request.

[...]

2.

An unauthorised biocidal product or an active substance for exclusive use in a biocidal product shall not be made available on the market or used for the purpose of any experiment or test which may involve, or result in, release of the biocidal product into the environment unless the competent authority has assessed the data submitted by the person interested in the making available of such product on the market and issued a test permit for that purpose which limits the quantities to be used and the areas to be treated and which may impose further conditions. The competent authority shall without delay inform the Commission and the other competent authorities of that test permit.
3.

Where any experiment or test takes place in a Member State other than the Member State where making available on the market of the biocidal product occurs, the applicant shall obtain experiment or test authorisation from the competent authority of the Member State in the territory of which the experiments or tests are to be conducted.

If the proposed experiments or tests referred to in paragraphs 1 and 2 may have harmful effects on human or animal health or any unacceptable adverse effect on the environment, the competent authority of the Member State concerned may prohibit them or allow them subject to such conditions as it considers necessary to prevent those consequences. The competent authority shall without delay inform the Commission and the other competent authorities of its decision.

4.

In order to ensure a harmonised approach, the Commission may adopt delegated acts in accordance with Article 72a to specify the [...] the minimum data to be submitted in accordance with paragraph 2.

[...]

CHAPTER X TREATED [...] ARTICLES

Article 47 Placing on the market of treated [...] articles

1.

This Article shall not apply to treated articles that have a primary biocidal function.
2.

A treated [...] article shall not be placed on the market unless all active substances contained in the biocidal products that it was treated with or incorporates are included in Annex I for the relevant product-type and any conditions specified therein are met.
3.

A treated [...] article shall be labelled with the following information if the active substances contained in the biocidal products that it was treated with or incorporates are intended to be released under normal or reasonably foreseeable conditions of use:

(a) a statement that the treated article was treated with or incorporates biocidal products;

(b) where substantiated, the biocidal property attributed to the treated article;

(d) [...] any relevant hazard or precautionary statement or the address of a website containing that information.

4.

Where the active substances contained in the biocidal products that the treated article was treated with or incorporates are not intended to be released under normal or reasonably foreseeable conditions of use, it shall be labelled with:

(a) a statement that the treated article was treated with or incorporates biocidal products;

and

(b) the address of a website containing the name of all active substances contained in those biocidal products.

5.

The labelling shall be clearly visible, easily legible and appropriately durable. Where necessary because of the size or the function of the treated [...] article, the labelling shall be printed on the packaging, on the instructions for use or on the warranty [...].
6.

In order to ensure a harmonised approach, the Commission may adopt delegated acts in accordance with Article 72a to specify detailed rules for the application of paragraph 2.

Those detailed rules may include appropriate notification procedures. The Commission may also, at the request of a Member State, decide by means of delegated acts in accordance with Article 72a whether a specific product is a biocidal product or falls within the scope of this article.

7.

The Commission may adopt implementing rules further specifying the labelling requirements under paragraph 3, 4 and 5 [in accordance with the regulatory procedure referred to in Article 72(3)].
8.

Where there are serious indications that an active substance contained in a biocidal product that a treated article is treated with or incorporates does not meet the conditions laid down in Article 4(1) or 5(2), the Commission shall review the inclusion of that active substance in Annex I in accordance with Article 13(1).

CHAPTER XI DATA PROTECTION AND DATA-SHARING

Article 48 Protection of data held by competent authorities or the Agency

1.

Without prejudice to Articles 51 and 52, data submitted for the purposes of this Regulation shall not be used by competent authorities or the Agency for the benefit of a subsequent applicant, except where:

(a) the subsequent applicant has [...] a letter of access [...];

(b) the relevant time limit for data protection has expired. [...]

2.

When [...] submitting data to a competent authority or to the Agency for the purposes of this Regulation the applicant shall also provide a list of all data submitted. In the list it shall specify whether it is the data owner [...] or [...] holds a letter of access [...]. In the former case, the applicant shall indicate whether it claims data protection for the data submitted, whether it has previously been protected anywhere in the Union and, if so, when any data protection period expires. In the latter case, the list shall contain the name and contact details of the data owner. The applicant shall inform the competent authority or the Agency about any changes to the ownership of the data.
3.

On receipt of the list referred to in paragraph 2, the competent authorities shall send it to the Agency.
4.

The list referred to in paragraph 2 shall be entered by the Agency in the Biocides Data Sharing Register referred to in Article 62. This shall include:

(a) the name [...] of the data owner;

(b) the contact details of the data owner;

(d) the date of submission of the relevant information to the competent authority or to the Agency.

5.

Notwithstanding Article 61(2), [...] the advisory scientific committees set up under Commission Decision 2004/210/EC setting up Scientific Committees in the field of consumer safety, public health and the environment [...] shall also have access to the data referred to in paragraph 4. The data referred to in paragraph 4(a), (c) and (d) shall be made publicly available.

Article 49 Data protection periods

1.

Data submitted for the purposes of Directive 98/8/EC or of this Regulation shall benefit from data protection under the conditions laid down in this Article. The protection period for the data shall start when they are submitted for the first time.

Data protected under Directive 98/8/EC or under this Article or for which the protection period expired under Directive 98/8/EC or under this Article shall not be protected again.

2.

The protection period for data submitted with a view to the inclusion of an existing active substance in Annex I shall end 10 years from the first day of the month following the date of adoption of a decision in accordance with Article 8a on the inclusion of the relevant active substance in Annex I for the particular product-type.

The protection period for data submitted with a view to the inclusion of a new active substance in Annex I shall end 15 years from the first day of the month following the date of adoption of a decision in accordance with Article 8a on the inclusion of the relevant active substance in Annex I for the particular product-type.

The protection period for new data submitted with a view to the renewal or review of the inclusion of an active substance in Annex I shall end 5 years from the first day of the month following the date of the adoption of a decision in accordance with Article 12(4) concerning the renewal or the review [...].

3.

The protection period for data submitted with a view to the authorisation of a biocidal product containing only existing active substances shall end 10 years from the date of the first decision concerning the authorisation of the product.

The protection period for data submitted with a view to the authorisation of a biocidal product containing a new active substance shall end 15 years from the date of the first decision concerning the authorisation of the product.

The protection period for new data submitted with a view to the renewal or amendment of the authorisation of a biocidal product shall end 5 years from the date of the concerning the renewal or amendment of the authorisation.

[...]

Article 50 Letter of access

1.

A letter of access shall contain at least the following information:

(a) the name and contact details of the data owner and the beneficiary;

(b) the name of the active substance or biocidal product for which access to the data is authorised;

(d) a list of the submitted data to which the letter of access grants citation rights.

[...]

2.

Revocation of a letter of access [...] shall not affect the validity of the authorisation issued on the basis of the letter of access in question.

Article 51 [...] Data sharing

1.

In order to avoid animal testing, testing on vertebrate animals for the purposes of this Regulation shall be undertaken only as a last resort. Testing on vertebrate animals shall not be repeated for the purposes of this Regulation.
2.

Any person intending to perform tests or studies involving vertebrate animals or non-vertebrate animals, hereinafter "the prospective applicant", shall ask the competent authority or the Agency whether such tests or studies have already been submitted in connection with a previous application under either this Regulation or Directive 98/8/EC. The competent authority or the Agency shall verify if there is any information on such tests or studies in the Biocides Data Sharing Register.

Where those tests or studies have already been submitted in connection with a previous application, under either this Regulation or Directive 98/8/EC, the competent authority or the Agency shall without delay communicate the name and contact details of the data owner [...]

to the prospective applicant.

Where the data acquired under those tests or studies are still protected under Article 49, [...]

the prospective applicant:

(a) shall, in the case of data involving tests on vertebrate animals; and

(b) may, in the case of data not involving tests on vertebrate animals,

request from the data owner [...] the right to refer to the tests or studies.

[...]

Article 52 Compensation for [...] data sharing

1.

Where a request has been made in accordance with Article 51(2), the prospective applicant and the data owner [...] shall make every effort to reach an agreement on the sharing of the results of the tests or studies requested by the prospective applicant. Such an agreement may be replaced by submission of the matter to a formal and binding arbitration procedure administered under national law.
2.

Where such agreement is reached, the data owner [...] shall make the data available to the prospective applicant [...] and shall give the prospective applicant permission to refer to the data owner's tests or studies.
3.

Where no such agreement is reached within 60 days of a request made according to Article 51(2) with respect to data involving tests on vertebrate animals, the prospective applicant shall without delay inform the Agency and the data owner [...] accordingly. Within 60 days of being informed about the failure to reach an agreement, the Agency shall give the prospective applicant the right to refer to those tests or studies [...]. National courts shall decide on the proportionate share of the cost that the prospective applicant shall pay to the data owner.
4.

Compensation for data sharing shall be determined in a fair, transparent and non- discriminatory manner, having regard to the guidance established by the Agency. The prospective applicant shall be required to share only in the costs of information that it is required to submit for the purposes of this Regulation.
5.

An appeal may be brought, in accordance with Article 67, against Agency decisions under paragraph 3 of this Article.

Article 53 Use of data for subsequent applications [...]

1.

[...] Where all data protection periods according to Article 49 have expired in relation to an existing active substance or an authorised biocidal product, the receiving competent authority or the Agency may agree that a subsequent applicant for authorisation may refer to data provided by the first applicant in so far as the subsequent applicant can provide evidence that:

(a) the active substance is technically equivalent to the existing active substance, including the degree of purity and the nature of any relevant impurities; or

(b) the biocidal product is the same as the one already authorised, or the differences between them are not significant in relation to the risk assessment and the active substance(s) in the biocidal product are technically equivalent to those in the biocidal product already authorised, including the degree of purity and the nature of any impurities.

An appeal may be brought, in accordance with Article 67, against Agency decisions under the first subparagraph of this paragraph.

2.

Notwithstanding paragraph 1, subsequent applicants shall provide the following data accordingly to the receiving competent authority or the Agency, as applicable:

(a) all necessary data for the identification of the biocidal product, including its

-

composition;

(b) the data needed to identify the active substance and to establish technical equivalence of the active substance;

(c) [...] the data needed to demonstrate the comparability of the risk from and efficacy of the biocidal product to that of the authorised biocidal product [...].

CHAPTER XII INFORMATION AND COMMUNICATION Section 1 Monitoring and reporting

Article 54 Compliance with requirements

1.

Member States shall make the necessary arrangements for the monitoring of biocidal products and treated [...] articles which have been placed on the market [...] to establish whether they comply with the requirements of this Regulation. Regulation (EC) No 765/2008 of the European Parliament and of the Council setting out the requirements for accreditation and market surveillance relating to the marketing of products and repealing Regulation (EEC) No 339/93 shall apply accordingly.
2.

Member States shall make the necessary arrangements for official controls to be carried out in order to enforce compliance with this Regulation.
3.

Every three years, starting in ...

*, Member States shall submit to the Commission a report on the implementation of this Regulation in their respective territories. The report shall include:

(a) information on the results of official controls carried out in accordance with paragraph 2;

*

OJ: Insert the date mentioned in Article 85, second subparagraph.

(b) information on any poisonings or occupational diseases involving biocidal products.

The Commission shall within one year of receipt of the reports referred to in the first subparagraph prepare and publish a composite report.

4.

The Commission shall draw up a report on the implementation of this Regulation and, in particular, on the functioning of the Union authorisation procedure and mutual recognition, by

1 January [2023]. The Commission shall submit the report to the European Parliament and the Council.

Article 55 Confidentiality

1.

Regulation (EC) No 1049/2001 of the European Parliament and of the Council regarding public access to European Parliament, Council and Commission documents and the rules of the Management Board of the Agency, adopted in accordance with Article 118(3) of Regulation (EC) No 1907/2006, shall apply to documents held by the Agency for the purposes of this Regulation.
2.

Disclosure of the following information shall normally be deemed to undermine the protection of the commercial interests or the privacy or safety of the persons concerned:

(a) details of the full composition of a biocidal product;

(b) [...] the precise tonnage of the active substance or biocidal product manufactured or placed on the market;

(c) links between a manufacturer of an active substance and the person responsible for the placing of a biocidal product on the market or between the person responsible for the placing of a biocidal product on the market and the distributors of the product;

(e) names and addresses of persons involved in testing on vertebrate animals.

However, where urgent action is essential to protect human health, safety or the environment or for other reasons of overriding public interest, the Agency or the competent authorities may disclose the information referred to in this paragraph.

3.

Any person submitting information related to an active substance to the Agency or a competent authority for the purposes of this Regulation can request that the information in Article 56(2) shall not be made available including a justification as to why the disclosure of the information could be harmful for their commercial interests or those of any other party concerned.
4.

Information accepted as confidential by a competent authority or the Agency shall be treated as confidential by the other competent authorities, the Agency and the Commission.

Article 56 Electronic public access

1.

The following information held by the competent authorities, the Agency or, as appropriate, the Commission on active substances shall be made publicly available free of charge:

(a) without prejudice to paragraph 2 (e), where available, the ISO name and the name in the International Union of Pure and Applied Chemistry (IUPAC) nomenclature [...];

(b) if applicable, the name [...] as given in European Inventory of Existing Commercial Chemical Substances (EINECS);

(d) physicochemical data [...] and data on pathways and environmental fate and behaviour;

(e) the result of each toxicological and ecotoxicological study;

(f) acceptable exposure level or predicted no-effect concentration established in accordance with Annex VI to this Regulation;

(g) the guidance on safe use provided in accordance with Annex II and Annex III to this Regulation;

(h) analytical methods if requested in accordance with Annex II [...] to this Regulation which make it possible to detect an active substance or its residues when discharged into the environment as well as to determine the direct exposure of humans.

If the information listed in the first subparagraph concerns a new active substance, it shall be made publicly available only after the date on which the inclusion of the new active substance in Annex I to this Regulation becomes effective.

2.

The following information on active substances whether on their own, in mixtures or in materials or articles, or information on biocidal products shall be made publicly available, free of charge, except where a party submitting the information submits a justification in accordance with Article 55(3), accepted as valid by the competent authority, the Agency or, as appropriate, the Commission, as to why such publication is potentially harmful for the commercial interests of the applicant or any other party concerned:

(a) if essential to classification and labelling, the degree of purity of the substance and the identity of impurities and/or additives which are known to be dangerous;

(b) the study summaries or robust study summaries of the information referred to in paragraph 1(d) and (e) of this Article;

(d) the trade name(s) of the substance;

(e) subject to Article 24 of Regulation (EC) No 1272/2008, the name in the IUPAC nomenclature for active substances referred to in paragraph 1(a) of this Article that are only used as one or more of the following:

(i) in scientific research and development;

(ii) in product and process orientated research and development.

3.

After the authorisation has been granted, confidentiality shall not in any case apply to:

(a) the name and address of the applicant;

(b) the name and address of the biocidal product manufacturer;

(d) the content of the active substance or substances in the biocidal product and the name of the biocidal product;

(e) physical and chemical data concerning the biocidal product;

(f) any ways of rendering the active substance or biocidal product harmless;

(g) a summary of the results of the tests required pursuant to Article 18 to establish the product's efficacy and effects on humans, animals and the environment and, where applicable, its ability to promote resistance;

(h) recommended methods and precautions to reduce dangers from handling, [...] transport and use as well as from fire or other hazards;

(i) safety data sheets;

(j) methods of analysis referred to in point (c) of Article 16(1);

(k) methods of disposal of the product and of its packaging;

(l) procedures to be followed and measures to be taken in the case of spillage or leakage;

(m) first aid and medical advice to be given in the case of injury to persons.

Article 57 Record-keeping and reporting

1.

Authorisation holders and professional users of biocidal products shall keep records of the biocidal products they produce, place on the market or use for at least three years after the authorisation was cancelled or has lapsed expired or use has ceased. They shall make available the relevant information contained in these records to the competent authority on request. Where the professional user is an employee, the record-keeping and reporting duties shall lie with the employer.
2.

The Commission shall adopt implementing measures to specify the form and content of the information in the records, and to ensure the uniform application of paragraph 1, [in accordance with the regulatory procedure referred to in Article 72(3)].

Section 2 Information about biocidal products

Article 58 Classification, packaging and labelling of biocidal products

1.

Biocidal products shall be classified, packaged and labelled in accordance with Directive 1999/45/EC and, where applicable, Regulation (EC) 1272/2008 and the approved summary of biocidal product characteristics, in particular the hazard statements and the precautionary statements, as referred to in point (i) of Article 20(2) or (3), as applicable.

In addition, products which may be mistaken for food, including drink, or feed shall be packaged to minimise the likelihood of such a mistake being made. If they are available to the general public, they shall contain components to discourage their consumption.

2.

Labels shall not be misleading and, in any case, shall not mention the indications `low-risk biocidal product', `non-toxic', `harmless' or similar indications. In addition, the label must show clearly and indelibly the following information:

(a) the identity of every active substance and its concentration in metric units;

(b) the authorisation number allocated to the biocidal product by the competent authority or the Commission;

(bb) the name and address of the authorisation holder;

(d) the uses for which the biocidal product is authorised;

(e) directions for use and the dose rate, expressed in metric units, for each use provided for under the terms of the authorisation;

(f) particulars of likely direct or indirect adverse side effects and any directions for first aid;

(g) if accompanied by a leaflet, the sentence `Read attached instructions before use';

(h) directions for safe disposal of the biocidal product and its packaging, including, where relevant, any prohibition on reuse of packaging;

(i) the formulation batch number or designation and the expiry date relevant to normal conditions of storage;

(j) where applicable, the period of time needed for the biocidal effect, the interval to be observed between applications of the biocidal product or between application and the next use of the product treated, or the next access by man or animals to the area where the biocidal product has been used, including particulars concerning decontamination means and measures and duration of necessary ventilation of treated areas; particulars for adequate cleaning of equipment; particulars concerning precautionary measures during use [...]and transport;

(k) where applicable, the categories of users to which the biocidal product is restricted;

(l) where applicable, information on any specific danger to the environment particularly concerning protection of non-target organisms and avoidance of contamination of water;

(m) for biocidal products containing micro-organisms, labelling requirements in accordance with Directive 2000/54/EC.

By way of derogation from the first subparagraph, where this is necessary because of the size or the function of the biocidal product, the information referred to in points (c), (e), (f), (h), (i), (j) and (l) may be indicated on the packaging or on an accompanying leaflet integral to the packaging.

3.

Member States may require:

(a) the provision of samples, models or drafts of the packaging, labelling and leaflets;

(b) that biocidal products placed on the market in their territories be labelled in their official language or languages.

Article 59 Safety Data Sheets

Safety-data sheets for active substances and biocidal products shall be prepared and made available in accordance with Article 31 of Regulation (EC) No 1907/2006 [...].

Article 60 [...] Register for Biocidal Products

1.

The Commission shall establish and maintain a [...] Register for Biocidal Products.
2.

The [...] Register for Biocidal Products shall be used for the exchange of information between competent authorities, the Agency and the Commission.
3.

Applicants shall use the [...] Register for Biocidal Products to generate and submit the application form for all procedures relating to the authorisation of biocidal products, mutual recognition and the granting of parallel trade permits.
4.

Competent authorities shall update in the [...] Register for Biocidal Products the information relating to biocidal products which have been authorised within their territory or for which a national authorisation has been refused, amended, renewed or cancelled. The Commission shall update the information relating to biocidal products which have been authorised in the Union or for which a Union authorisation has been refused, amended, renewed or cancelled.
5.

The Commission may adopt detailed rules on the types of information to be entered in the [...]

Register for Biocidal Products and the procedures related to it, [in accordance with the advisory procedure referred to in Article 72(2)].

Article 61 Biocides Data Sharing Register

1.

The Agency shall establish and maintain a Biocides Data Sharing Register.
2.

The Biocides Data Sharing Register shall contain information provided by competent authorities and the Agency in accordance with paragraphs 3 and 4 of Article 48.

Without prejudice to other Union law on public access to information, the Register shall be accessible only to competent authorities, the Agency and the Commission. [...]

Article 62 Advertising

1.

Any advertisement for biocidal products shall, in addition to complying with Regulation (EC)

No 1272/2008, include the sentences `Use biocides safely. Always read the label and product information before use.'. The sentences shall be clearly distinguishable in relation to the whole advertisement.

2.

Advertisers may replace the word `biocides' in the prescribed sentences with a clear reference to the product-type [...] being advertised.
3.

Advertisements for biocidal products shall not refer to the product in a manner which is misleading in respect of the risks from the product to human health or the environment. In any case, the advertising of a biocidal product shall not mention `low-risk biocidal product', `non-toxic', `harmless' or any similar indication.

Article 63 Poison control

1.

Member States shall appoint a body or bodies responsible for receiving information on biocidal products which have been placed on the market, including information on the chemical composition of such products, and for making such information available in cases where suspected poisoning arises from biocidal products.

Member States may decide to appoint the body or bodies that have already been appointed in accordance with Article 45 of Regulation (EC) No 1272/2008 to carry out the tasks under this Article.

2.

The bodies that Member States appoint shall provide all the requisite guarantees for maintaining the confidentiality of information received. Such information may be used only for the following purposes:

(a) to meet medical demand by formulating preventive and curative measures, in particular in case of emergency;

(b) where requested by the Member State, to undertake statistical analysis to identify where improved risk management measures may be needed.

CHAPTER XIII THE AGENCY

Article 64 Role of the Agency

The Agency shall carry out the tasks conferred on it by [...] this Regulation.

Article 65 Biocidal Products Committee

1.

A Biocidal Products Committee is hereby established within the Agency.

The Biocidal Products Committee shall be responsible for preparing the opinion of the Agency on the following issues:

(a) applications for inclusion and renewal of inclusion of active substances in Annex I;

(b) review of inclusion of active substances in Annex I;

(d) applications for Union authorisation of biocidal products and for renewal, cancellation and amendments of Union authorisation;

(e) scientific and technical matters concerning mutual recognition in accordance with Article 30;

(f) at the request of the Commission any other questions that arise from the operation of this Regulation relating to risks to human or animal health or the environment or technical guidance.

2.

Each Member State shall be entitled to appoint a member of the Biocidal Products Committee.

[...]

3.

Committee members shall be appointed for their role and experience in performing the tasks specified in paragraph 1 and may work within a competent authority. They shall be supported by the scientific and technical resources available to Member States. To this end, Member States shall provide adequate scientific and technical resources to Committee members that they have nominated. [...]
4.

Article 85, paragraphs 8 and 9, and Articles 87 and 88 of Regulation (EC) No 1907/2006 shall apply mutatis mutandis to the Biocidal Products Committee.

Article 66 Operation of the Biocidal Products Committee and the Secretariat of the Agency

1.

Articles 78 to 84, 89 and 90 of Regulation (EC) No 1907/2006 shall apply mutatis mutandis taking into account the role of the Agency with respect to this Regulation.
2.

The Secretariat of the Agency referred to in point (g) of Article 76(1) of Regulation (EC)

No 1907/2006 shall undertake the following tasks:

(a) establishing and maintaining the Biocides Data Sharing Register;

(b) performing the tasks relating to the validation of the applications referred to in Articles 7(3) and (4), 11(3) and 34(3) and (4), and 36(3) of this Regulation;

*

In the Commission's initial proposal the whole of Article 85 would have applied, mutatis mutandis, meaning in particular that the ECHA Management Board would have selected Committee members from among Member States' nominees and Committee members would have served in a personal capacity.

(c) providing technical and scientific guidance and tools for the application of this Regulation by the Commission and the competent authorities of Member States;

(d) providing advice and assistance to applicants for the inclusion of an active substance in Annex I or for a Union authorisation;

(e) preparing explanatory information on this Regulation;

(f) establishing and maintaining database(s) with information on active substances and biocidal products;

(g) at the request of the Commission, providing technical and scientific support to improve cooperation between the Union, competent authorities, international organisations and third countries on scientific and technical issues relating to biocidal products;

(h) notification of decisions taken by the Agency;

(i) specification of formats and software packages for the submission of information to the Agency.

The Secretariat shall also be responsible for preparing decisions of the Agency on which competent authority shall be the evaluating competent authority when the Agency is so requested pursuant to Articles 7(1), 11(3), 34(1) and 36(3).

3.

The Secretariat shall make the information identified in Article 56(1) and (2) in the database(s) publicly available, free of charge, over the Internet, except where a request made under Article 55(3) is considered justified. The Agency shall make other information in the databases available on request in accordance with Article 55.

Article 67 Appeal

1.

Appeals against decisions of the Agency taken pursuant to Articles 7(1 and 2), 11(3), 34(1 and 2), 36(3), 52(3) and 53(1) shall lie with the Board of Appeal.

Articles 92(1) and (2), 93 and 94 of Regulation (EC) No 1907/2006 shall apply to appeal procedures lodged under this Regulation.

A fee may be payable, in accordance with Article 70(2) of this Regulation, by the person bringing an appeal.

2.

An appeal lodged pursuant to paragraph 1 shall have suspensive effect.

Article 68 The budget of the Agency

1.

For the purposes of this Regulation, the revenues of the Agency shall consist of:

(a) a subsidy from the Union, entered in the general budget of the European Union

-

(Commission Section);

(b) the fees paid to the Agency in accordance with this Regulation;

(d) any voluntary contribution from Member States.

2.

Revenue and expenditure for activities related to this Regulation and [...] to [...] Regulation

(EC) No 1907/2006 shall be dealt with separately in the Agency's budget and shall have separate budgetary and accounting reporting.

Revenue of the Agency referred to in Article 96(1) of Regulation (EC) No 1907/2006 shall not be used for carrying out tasks under this Regulation. Revenue of the Agency referred to in paragraph 1 of this Article shall not be used for carrying out tasks under Regulation (EC) No 1907/2006.

Article 69 Formats and software for submission of information to the Agency

The Agency shall specify formats and make them available free of charge, and shall specify software packages and make them available on its website for submissions to the Agency. The competent authorities and applicants shall use these formats and packages in their submissions to the Agency pursuant to this Regulation.

The format of the technical dossier referred to in Articles 6(1), 11(1), 18 and 36(4) shall be IUCLID.

CHAPTER XIV FINAL PROVISIONS

Article 70 Fees and charges

1.

The Commission shall adopt delegated acts in accordance with Article 72a establishing rules concerning:

(a) the [...] fees payable to the Agency; and

(b) a harmonised structure of fees and conditions of payment for fees payable to the Agency or to Member States' competent authorities.

[...]

2.

The fees, harmonised structure of fees and conditions of payment referred to in paragraph 1 shall respect the following principles:

(a) a proportion of fees paid to the Agency shall be transferred to the evaluating competent

-

authority;

(b) partial reimbursement of the fee if the applicant fails to submit the information requested within the specified deadline;

(c) the specific needs of small and medium-sized enterprises within the meaning of Recommendation 2003/361/EC concerning the definition of micro, small and medium- sized enterprises

-

may be taken into consideration;

(d) the fee structure shall take into account whether information has been submitted jointly or separately;

(e) in duly justified circumstances and where it is accepted by the competent authority or the Agency, it shall be possible to waive the fee;

(f) an annual fee shall be paid by persons having placed biocidal products on the market in accordance with a Union authorisation for as long as those products continue to be placed on the market. Member States' competent authorities may charge an annual fee in respect of biocidal products placed on the market in accordance with a national authorisation; and

(g) the structure and amount of the fees shall take account of the work required by this Regulation to be carried out by the Agency and Member States' competent authorities and shall be set at such a level as to ensure that the revenue derived from the fees, when combined with other sources of the Agency's revenue pursuant to this Regulation, is sufficient to cover the cost of the services delivered.

3.

Member States shall oblige those who place or are seeking to place biocidal products on the market and those supporting inclusion of active substances in Annex I to pay fees in accordance with the harmonised structure of fees and conditions of payment to be adopted in accordance with paragraph 1. Member States may collect charges for other services they provide.
4.

In accordance with the rules referred to in paragraph 1, the Agency shall oblige those who place or are seeking to place biocidal products on the market and those supporting inclusion of active substances in Annex I to pay fees. The structure and the amount of fees payable to the Agency shall be determined in accordance with paragraph 1. The Agency may collect charges for other services it provides.

Article 71 Competent authorities

1.

Member States shall designate a competent authority or competent authorities responsible for the application of this Regulation.

[...]

2.

Member States shall establish national helpdesks to provide advice to applicants, in particular to SMEs, and any other interested parties on their respective responsibilities and obligations under this Regulation. This advice shall include, in particular, advice about the possibility of adapting the data requirements of Article 6, the grounds on which such an adaptation can be made and on how to prepare a proposal. It shall be in addition to the advice and assistance that the Secretariat of the Agency shall provide in accordance with Article 66(2)(d).
3.

Member States shall inform the Commission of the names and addresses of the designated competent authorities and national helpdesks by 1 January [2013]. Member States shall, without undue delay, inform the Commission of any changes to the names and addresses of the competent authorities or national helpdesks.

The Commission shall make publicly available a list of competent authorities and national helpdesks.

Article 72 [Standing Committee

1.

The Commission shall be assisted by the Standing Committee on Biocidal Products.
2.

Where reference is made to this paragraph, Articles 3 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
3.

Where reference is made to this paragraph, Articles 5 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.

The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months.]

[...]

Article 72a Exercise of the delegation

1.

The power to adopt the delegated acts referred to in Articles 6(4), 8a, 12(5), 13(1), 19(3), 21(5), 33(2), 42, 46, 70(1), 74 and 77(1) shall be conferred on the Commission for a period of five years following the entry into force of this Regulation. The Commission shall make a report in respect of the delegated powers at the latest six months before the end of the five year period. The delegation of power shall be automatically extended for periods of an identical duration, unless the European Parliament or the Council revokes it in accordance with Article 72b.
2.

As soon as it adopts a delegated act, the Commission shall notify it simultaneously to the European Parliament and to the Council.
3.

The power to adopt delegated acts is conferred on the Commission subject to the conditions laid down in Articles 72b and 72c. Where imperative grounds of urgency so require, Article 72d shall apply.

Article 72b Revocation of the delegation

1.

The delegation of power referred to in Article 72a(1) may be revoked at any time by the European Parliament or by the Council.
2.

The institution which has commenced an internal procedure for deciding whether to revoke the delegation of powers shall endeavour to inform the other institution and the Commission within a reasonable time before the final decision is taken, indicating the delegated powers which could be subject to revocation and possible reasons for a revocation.
3.

The decision of revocation shall put an end to the delegation of the powers specified in that decision. It shall take effect immediately or at a later date specified therein. It shall not affect the validity of the delegated acts already in force. It shall be published in the Official Journal of the European Union.

Article 72c Objections to delegated acts

1.

The European Parliament or the Council may object to the delegated act within a period of two months from the date of notification.

At the initiative of the European Parliament or the Council this period shall be extended by two months.

2.

If, on expiry of that period, neither the European Parliament nor the Council has objected to the delegated act, it shall be published in the Official Journal of the European Union and shall enter into force on the date stated therein.

The delegated act may be published in the Official Journal of the European Union and enter into force before the expiry of that period if the European Parliament and the Council have both informed the Commission of their intention not to raise objections.

3.

If the European Parliament or the Council objects to the delegated act, it shall not enter into force. The institution which objects shall state the reasons for objecting to the delegated act.

Article 72d Urgency procedure

1.

A delegated act adopted under the urgency procedure shall enter into force without delay and apply as long as no objection is expressed in accordance with paragraph 2. The notification of the act to the European Parliament and to the Council shall state the reasons for the use of the urgency procedure.
2.

The European Parliament and the Council may within a period of six weeks from the date of notification object to the delegated act. In such a case, the act shall cease to be applicable. The institution which objects shall state the reasons for objecting to the delegated act.

Article 73 Adaptation to scientific and technical progress

In order to allow the provisions of this Regulation to be adapted to scientific and technical progress, the Commission shall adopt delegated acts in accordance with Article 72a as regards the adaptation of the Annexes to such scientific and technical progress.

Article 74 Updating of Annex I

In order to facilitate a smooth transition from Directive 98/8/EC to this Regulation, the Commission shall, by 1 January 2013, [adopt a delegated act in accordance with [...] Article 72a] to amend Annex I with effect from the date of applicability of this Regulation in order to take into account any amendment to Annex I adopted under Directive 98/8/EC and not reflected in Annex I to this Regulation.

Article 75 Penalties

Member States shall lay down the provisions on penalties applicable to infringement of the provisions of this Regulation and shall take all measures necessary to ensure that they are implemented. The penalties provided for must be effective, proportionate and dissuasive. The Member States shall notify those provisions to the Commission no later than 1 December [2015]

and shall notify the Commission without delay of any subsequent amendment affecting them.

Article 76 Safeguard clause

Where, based on new evidence, a Member State has justifiable grounds to consider that a biocidal product, although authorised in accordance with this Regulation, constitutes a serious risk to human or animal health or to the environment, it may take appropriate provisional measures. The Member State shall without delay inform the Commission and the other Member States accordingly and give reasons for its decision based on the new evidence.

The Commission shall[, in accordance with the regulatory procedure referred to in Article 72(3)], either authorise the provisional measure for a time period defined in the decision or require the Member State to revoke the provisional measure.

Article 77 Transitional measures

1.

The Commission shall carry on with the work programme for the systematic examination of all existing active substances commenced in accordance with Article 16(2) of Directive 98/8/EC with the aim of achieving it by 14 May 2014. To that end, the Commission may adopt delegated acts in accordance with Article 72a to carry out the work programme and to specify the related rights and obligations of the competent authorities and the participants in the programme. [...]

Depending upon the progress of the work programme, the Commission may adopt delegated acts in accordance with Article 72a to extend the duration of the work programme for a determined period. [...]

In order to facilitate a smooth transition from Directive 98/8/EC to this Regulation, during the work programme the Commission shall decide by means of a delegated act adopted in accordance with Article 72a that an active substance shall be included in Annex I to this Regulation and under which conditions, or, in cases where the requirements of Article 4 are not satisfied or where the requisite information and data have not been submitted within the prescribed period, that such an active substance shall not be included in Annex I to this Regulation. Where the decision is to include an active substance in Annex I it shall specify the date of inclusion.

2.

By way of derogation from Articles 15(1), 16(1) and 18(1) of this Regulation, and without prejudice to paragraphs 1 and 3 of this Article, a Member State may continue to apply its current system or practice of placing biocidal products on the market until two years after the date of inclusion of all active substances in Annex I. It may, [...] according to its national rules, authorise the placing on the market in its territory only of a biocidal product containing existing active substances which have been or are being evaluated under Regulation (EC)

No 1451/2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market but which have not yet been included in Annex I to this Regulation for that product-type.

By derogation from the first subparagraph, in the case of a decision not to include an active substance in Annex I to this Regulation, a Member State may continue to apply its current system or practice of placing biocidal products on the market for up to twelve months after the date of the decision not to include an active substance in Annex I in accordance with the third subparagraph of paragraph 1.

3.

Following a decision to include a particular active substance in Annex I to this Regulation for a specific product-type Member States shall ensure that authorisations for biocidal products of that product-type and containing that active substance are granted, modified or cancelled as appropriate in accordance with this Regulation within two years of the date of inclusion.

To that effect, those wishing to apply for the authorisation or mutual recognition in parallel of biocidal products of that product-type containing no active substances other than existing active substances shall submit applications for authorisation or mutual recognition in parallel to Member States' competent authorities no later than the date of inclusion of the active substance(s) in Annex I [...]. In the case of biocidal products containing more than one active substance, applications for authorisation shall be submitted no later than the date of inclusion of the last active substance for that product-type [...].

Where no application for authorisation or mutual recognition in parallel has been submitted in accordance with the second subparagraph:

(a) the biocidal product shall no longer be placed on the market with effect from 180 days after the date of inclusion of the active substance(s) in Annex I; and

(b) disposal [...] and use of existing stocks of the biocidal product may continue until 365 days after the date of inclusion of the active substance(s) in Annex I.

4.

Where a Member State's competent authority rejects the application for authorisation of a biocidal product submitted under paragraph 3 or decides not to grant authorisation, that biocidal product shall no longer be placed on the market 180 days after the date of such rejection or decision. Disposal and use of existing stocks of such biocidal products may continue until 365 days after the date of such rejection or decision.

Article 78 Transitional measures concerning active substances evaluated under Directive 98/8/EC

1.

The Agency shall be responsible for coordinating the process of evaluation of dossiers submitted after 1 January 2012 and shall facilitate the [...] evaluation by providing organisational and technical support to the Member States and the Commission.
2.

Dossiers submitted for the purposes of Directive 98/8/EC for which the evaluation has not been completed by 1 January 2013 shall continue to be evaluated by the competent authorities in accordance with the provisions of Directive 98/8/EC and, where relevant, Regulation (EC)

No 1451/2007.

Notwithstanding paragraph 1, the Agency shall also be responsible for coordinating the evaluation process of dossiers submitted for the purposes of Directive 98/8/EC for which the evaluation has not been completed by 1 January 2013 and shall facilitate the preparation of the evaluation by providing organisational and technical support to the Member States and the Commission from 1 January 2014.

Article 79 Transitional measures concerning low-risk biocidal products registered under Directive 98/8/EC

1.

Low-risk biocidal products as defined in Article 2(1) (b) of Directive 98/8/EC shall be registered in accordance with point (i) of Article 3(2) of Directive 98/8/EC. The provisions of Directive 98/8/EC shall apply to these products until the expiry of the registration. The registration shall not be renewable.
2.

Applications for the registration of low-risk biocidal products as defined in point (b) of Article 2(1) of Directive 98/8/EC shall be submitted at the latest twelve months after the date of inclusion in Annex IA of the active substance(s) in the low-risk biocidal product [...].

Low-risk biocidal products as defined in point (b) of Article 2(1) of Directive 98/8/EC for which an application was submitted in accordance with the first subparagraph may continue to be placed on the market until the date of the decision granting the registration or refusing to grant the registration. In the case of refusal to grant a registration to place such a low-risk biocidal product on the market, the biocidal product shall no longer be made available on the market 180 days after the date of the decision.

Low-risk biocidal products as defined in point (b) of Article 2(1) of Directive 98/8/EC for which an application was not submitted in accordance with the first subparagraph may continue to be made available on the market until 180 days after the date referred to in paragraph 1.

Disposal [...] and use of existing stocks of low-risk biocidal products which are not registered for the relevant use by the competent authority may continue until 365 days after the date of the decision referred to in the second subparagraph or twelve months after the date referred to in the third subparagraph, whichever is the later.

3.

This Regulation shall apply to low-risk biocidal products as defined in point (b) of Article 2(1) of Directive 98/8/EC from the date of the expiry of the registration referred to in paragraph 1.

Article 79a Transitional measures concerning biocidal products authorised under Directive 98/8/EC

1.

Biocidal products for which an authorisation in accordance with Articles 3 or 4 of Directive 98/8/EC was granted before the date of entry into force of this Regulation can continue to be made available on the market and used until the expiry date of the authorisation or its cancellation.
2.

This Regulation shall apply to biocidal products referred to in the first subparagraph from the date of the expiry of the authorisation or its cancellation.

Article 80 Transitional measures concerning in situ generated active substances

1.

Applications for authorisation of substances and mixtures [...] considered as biocidal products because they generate active substances and which were available on the market on ...
*

shall be submitted at the latest by ...

**.

2.

By way of derogation from Article 15(1), substances and mixtures [...] referred to in paragraph 1 which were available on the market on ...
*

and for which an application was submitted in accordance with paragraph 1 may continue to be made available on the market until the date of the decision granting the authorisation or refusing to grant the authorisation.

In the case of a decision refusing to grant the authorisation, the biocidal product shall no longer be placed on the market 180 days after such a decision.

By way of derogation from Article 15(1), substances and mixtures [...] referred to in paragraph 1 which were available on the market on ...

*

and for which an application was not submitted in accordance with paragraph 1 may continue to be made available on the market until 180 days after the date referred to in paragraph 1.

Disposal [...] and use of existing stocks of biocidal products which are not authorised for the relevant use by the competent authority or the Commission may continue until 365 days after the date of the decision referred to in the first subparagraph or twelve months after the date referred to in the second subparagraph, whichever is the later.

*

OJ: Insert the date referred to in the first subparagraph of Article 85.

** OJ: Insert the date corresponding to four years after that referred to in the second subparagraph of Article 85.

*

OJ: Insert the date referred to in the first subparagraph of Article 85.

Article 81 Transitional measures concerning treated [...] articles

1.

By way of derogation from Article 47 and without prejudice to Article 77, treated [...] articles that [...] were available on the market on ...
*

may, until the date of a decision concerning the inclusion or non-inclusion in Annex I for the relevant product type of the active substance(s)

contained in the biocidal products with which the articles were treated or that they incorporate, continue to be placed on the market if the application for the inclusion of the active substance(s) in Annex I for the relevant product type is submitted at the latest by ...

**.

2.

In the case of a decision not to include an active substance in Annex I for the relevant product type, treated [...] articles that were treated with or incorporate biocidal product(s) containing that active substance shall no longer be made available on the market [...] 180 days after such

a decision or as of ...

**, whichever is the later, unless an application for the inclusion has been submitted in accordance with the first paragraph.

Article 82 Transitional measures concerning food contact materials

1.

Applications for the authorisation of biocidal products which are food contact materials and which were available on the market on ...
*

shall be submitted at the latest by 1 January 2017.

By way of derogation from Article 15(1), food contact materials which were available on the market on ...

*

for which an application was submitted in accordance with the first subparagraph may continue to be placed on the market until the date of the decision granting the authorisation or refusing to grant the authorisation. In case of a refusal to grant an authorisation to place such biocidal product on the market, such biocidal product shall no longer be placed on the market within 180 days after such decision.
*

OJ: Insert the date referred to in the first subparagraph of Article 85.

** OJ: Insert the date corresponding to one year after that referred to in the second subparagraph of Article 85.

By way of derogation from Article 15(1), food contact materials which were available on the market on ...

*

for which an application was not submitted in accordance with the first subparagraph may continue to be made available on the market until 180 days after the date referred to in the first subparagraph.
2.

Disposal [...] and use of existing stocks of biocidal products which are not authorised for the relevant use by the competent authority or the Commission may continue until twelve months after the date of the decision referred to in the second subparagraph of paragraph 1 or twelve months after the date referred to in the third subparagraph of paragraph 1, whichever is the later.

Article 83 Transitional measures concerning access to the active substance dossier

1.

As of ...

*, manufacturers of active substances shall submit to the Agency for every active substance:

(a) a dossier complying with the requirements of Annex II; or

(b) a letter of access to a dossier complying with the requirements of Annex II; or

(c) a reference to a dossier complying with the requirements of Annex II and for which all data protection period have expired.

For the purposes of this paragraph and for existing active substances listed in Annex II to Regulation (EC) No. 1451/2007, the provisions on mandatory data sharing, as laid down in Articles 51 and 52, shall apply to all data included in the dossier.

*

OJ: Insert the date referred to in the first subparagraph of Article 85.
*

OJ: Insert the date corresponding to that referred to in the second subparagraph of Article 85.

The manufacturer, to whom a letter of access to the dossier on the active substance has been granted, is entitled to allow applicants for the authorisation of a biocidal product containing that active substance to make reference to that letter of access for the purposes of Article 18(1).

By way of derogation from Article 49, all data protection periods for substance/product-type combinations listed in Annex II of Regulation (EC) No. 1451/2007 but not yet included in Annex I of this Regulation shall end on 31 December 2025.

2.

The Agency shall make publicly available the list of manufacturers that have made a submission in accordance with paragraph 1 or for whom it has taken a decision in accordance with Article 52(3). The list shall also contain the names of persons who are participants in the work programme established under the first subparagraph of Article 77(1) or have taken over the role of the participant.
3.

As of ...

*, biocidal products containing an active substance, the manufacturer of which is not included in the list referred to in paragraph 2, shall not be placed on the market.

Without prejudice to Articles 43 and 77, disposal and use of existing stocks of biocidal products containing an active substance, the manufacturer of which is not included in the list referred to in paragraph 2, may continue until ...

**.

4.

For the purposes of paragraph 3, competent authorities shall carry out official controls as required by Article 54(2).
*

OJ: Insert the date corresponding to two years after that referred to in the second subparagraph of Article 85.

** OJ: Insert the date corresponding to three years after that referred to in the second subparagraph of Article 85.

Article 84 Repeal

Without prejudice to Articles 77, 78, 79 and 79a, Directive 98/8/EC is hereby repealed on the date of application of this Regulation.

References to the repealed Directive shall be construed as references to this Regulation.

Article 85 Entry into force

This Regulation shall enter into force on the 20th day following that of its publication in the Official Journal of the European Union.

It shall apply from 1 January [2013].

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels,

For the European Parliament For the Council The President The President

[Annexes omitted.]

====================

2. Originele weergave

Open document als PDF

3. Meer informatie

verder

Proposal for a Regulation of the European Parliament and of the Council concerning the placing on the market and use of biocidal products - Hoofdinhoud

Inhoudsopgave van deze pagina:

Delen

1.

Tekst

2.

Originele weergave

3.

Meer informatie

Zoeken:

Laatste nieuws:

publicatiedatum	13-10-2010
kenmerk	6564/4/10 REV 4